Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

There were 210,165,657 shares of the registrant’s common stock, par value $0.10 per share, issued and outstanding as of April 30, 2015.

This report contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 concerning our business, consolidated financial condition and results of operations. The Securities and Exchange Commission (“SEC”) encourages companies to disclose forward-looking statements so that investors can better understand a company’s future prospects and make informed investment decisions. Forward-looking statements are subject to risks and uncertainties, many of which are outside our control, which could cause actual results to differ materially from these statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements can be identified by such words as “anticipates,” “believes,” “plan,” “assumes,” “could,” “should,” “estimates,” “expects,” “intends,” “potential,” “seek,” “predict,” “may,” “will” and similar references to future periods. All statements other than statements of historical facts included in this report regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected future operating results, expectations regarding the results of restructuring and other programs, anticipated levels of capital expenditures and expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings.

Please refer to Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 for important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

We present financial information that conforms to Generally Accepted Accounting Principles in the United States of America (“U.S. GAAP”). We also present financial information that does not conform to U.S. GAAP, which we refer to as non-U.S. GAAP, as our management believes it is useful to investors. In addition, non-U.S. GAAP measures are used by management to review and analyze our operating performance and, along with other data, as internal measures for setting annual budgets and forecasts, assessing financial performance, providing guidance and comparing our financial performance with our peers. The non-U.S. GAAP information has limitations as an analytical tool and should not be considered in isolation from or as a substitute for U.S. GAAP information. It does not purport to represent any similarly titled U.S. GAAP information and is not an indicator of our performance under U.S. GAAP. Non-U.S. GAAP financial measures that we present may not be comparable with similarly titled measures used by others. Investors are cautioned against placing undue reliance on these non-U.S. GAAP measures. Further, investors are urged to review and consider carefully the adjustments made by management to the most directly comparable U.S. GAAP financial measure to arrive at these non-U.S. GAAP financial measures. See Note 4, “Segments” and our Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) for reconciliations of our non-U.S. GAAP financial measures to U.S. GAAP. Information reconciling forward-looking non-U.S. GAAP measures to U.S. GAAP measures is not available without unreasonable effort.

Our management may assess our financial results both on a U.S. GAAP basis and on a non-U.S. GAAP basis. Non-U.S. GAAP financial measures provide management with additional means to understand and evaluate the core operating results and trends in our ongoing business by eliminating certain one-time expenses and/or gains (which may not occur in each period presented) and other items that management believes might otherwise make comparisons of our ongoing business with prior periods and peers more difficult, obscure trends in ongoing operations or reduce management’s ability to make useful forecasts.

Our non-U.S. GAAP financial measures may also be considered in calculations of our performance measures set by the Organization and Compensation Committee of our Board of Directors for purposes of determining incentive compensation. The non-U.S. GAAP financial metrics mentioned above exclude items that we consider as unusual or special items. We evaluate unusual or special items on an individual basis. Our evaluation of whether to exclude an unusual or special item for purposes of determining our non-U.S. GAAP financial measures considers both the quantitative and qualitative aspects of the item, including among other things (i) its nature, (ii) whether or not it relates to our ongoing business operations, and (iii) whether or not we expect it to occur as part of our normal business on a regular basis.

As of January 1, 2014, the Company changed the segment performance measure in which the management assesses segment performance and makes allocation decisions by segment from operating profit (a U.S. GAAP financial measure) to Adjusted EBITDA (a non-U.S. GAAP financial measure). Adjusted EBITDA is defined as Earnings before Interest Expense, Taxes, Depreciation and Amortization, adjusted to exclude the impact of special items.

We also present our adjusted income tax rate or provision (“Core Tax Rate”). The Core Tax Rate is a measure of our U.S. GAAP effective tax rate, adjusted to exclude the tax impact from the special items that are excluded from our Adjusted Net Earnings and Adjusted EPS metrics as well as expense or benefit from any special taxes or tax benefits. The Core Tax Rate is an indicator of the taxes on our core business. The tax situation and effective tax rate in the specific countries where the excluded or special items occur will determine the impact (positive or negative) to the Core Tax Rate.

In our “Net Sales by Geographic Region,” “Components of Change in Net Sales by Segment” and in some of the discussions and tables that follow, we exclude the impact of foreign currency translation when presenting net sales information, which we define as “constant dollar.” Changes in net sales excluding the impact of foreign currency translation are non-U.S. GAAP financial measures. As a worldwide business, it is important that we take into account the effects of foreign currency translation when we view our results and plan our strategies. Nonetheless, we cannot control changes in foreign currency exchange rates. Consequently, when our management looks at our financial results to measure the core performance of our business, we may exclude the impact of foreign currency translation by translating our current period results at prior period foreign currency exchange rates. We also may exclude the impact of foreign currency translation when making incentive compensation determinations. As a result, our management believes that these presentations are useful internally and may be useful to investors.

	March 31,			December 31,
(In millions, except share data)	2015 (unaudited)			2014
ASSETS
Current assets:
Cash and cash equivalents	$	536.3		$	322.6
Trade receivables, net of allowance for doubtful accounts of $27.5 in 2015 and $28.8 in 2014		975.5			1,002.2
Income tax receivables		44.9			277.0
Other receivables		143.8			127.0
Inventories		744.3			695.3
Deferred taxes		91.9			105.6
Assets held for sale		47.3			69.3
Prepaid expenses and other current assets		92.6			122.1
Total current assets		2,676.6			2,721.1
Property and equipment, net		913.7			970.6
Goodwill		2,954.6			2,998.6
Intangible assets, net		837.5			872.2
Non-current deferred taxes		100.6			105.9
Other non-current assets		370.5			373.3
Total assets	$	7,853.5		$	8,041.7
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings	$	85.2		$	130.4
Current portion of long-term debt		1.3			1.1
Accounts payable		686.8			638.7
Deferred taxes		6.1			4.8
Liabilities held for sale		2.4			6.1
Accrued restructuring costs		52.9			55.8
Other current liabilities		759.5			894.0
Total current liabilities		1,594.2			1,730.9
Long-term debt, less current portion		4,261.8			4,282.5
Non-current deferred taxes		154.9			161.5
Other non-current liabilities		692.9			704.0
Total liabilities		6,703.8			6,878.9
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.10 par value per share, 50,000,000 shares authorized; no shares issued in 2015 and 2014		—			—
Common stock, $0.10 par value per share, 400,000,000 shares authorized; shares issued: 225,609,374 in 2015 and 224,683,653 in 2014; shares outstanding: 210,622,311 in 2015 and 210,531,894 in 2014		22.6			22.5
Additional paid-in capital		1,809.7			1,787.0
Retained earnings		517.6			448.5
Common stock in treasury, 14,987,063 shares in 2015 and 14,151,759 shares in 2014		(524.9	)		(481.4	)
Accumulated other comprehensive loss, net of taxes:
Unrecognized pension items		(219.2	)		(236.5	)
Cumulative translation adjustment		(455.3	)		(382.5	)
Unrealized net (loss) gains on derivative instruments		(0.8	)		5.2
Total accumulated other comprehensive loss, net of taxes		(675.3	)		(613.8	)
Total stockholders’ equity		1,149.7			1,162.8
Total liabilities and stockholders’ equity	$	7,853.5		$	8,041.7

	Three Months Ended
	March 31, (unaudited)
(In millions, except share data)	2015			2014
Net sales	$	1,746.4		$	1,827.7
Cost of sales		1,096.8			1,188.1
Gross profit		649.6			639.6
Selling, general and administrative expenses		427.1			447.4
Amortization expense of intangible assets acquired		22.6			31.2
Stock appreciation rights expense		2.9			0.5
Integration related costs		0.7			0.9
Restructuring and other charges		12.7			6.1
Operating profit		183.6			153.5
Interest expense		(58.5	)		(78.5	)
Foreign currency exchange gain (loss) related to Venezuelan subsidiaries		0.8			(15.0	)
Gain from Claims Settlement		—			21.1
Other income, net		5.4			—
Earnings before income tax provision		131.3			81.1
Income tax provision		34.1			10.2
Net earnings available to common stockholders	$	97.2		$	70.9
Net earnings per common share:
Basic	$	0.46		$	0.34
Diluted	$	0.46		$	0.33
Dividends per common share	$	0.13		$	0.13
Weighted average number of common shares outstanding:
Basic		208.9			206.7
Diluted		211.7			215.1

	Three Months Ended
	March 31, (unaudited)
(In millions)	2015			2014
Net earnings available to common stockholders	$	97.2		$	70.9
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization		54.8			68.3
Share-based incentive compensation		18.3			14.5
Profit sharing expense		9.8			9.5
Amortization of senior debt related items and other		0.6			2.4
Loss on debt redemption and refinancing activities		0.5			0.4
Other non-cash items		0.6			(1.6	)
Provisions for bad debt		2.1			1.7
Provisions for inventory obsolescence		3.1			4.1
Gain from Claims Settlement		—			(21.1	)
Deferred taxes, net		13.7			(1.6	)
Net (gain) loss on disposals of property and equipment and other		(3.3	)		0.1
Changes in operating assets and liabilities:
Trade receivables, net		8.5			(9.1	)
Inventories		(83.8	)		(90.5	)
Other assets		(45.3	)		(21.1	)
Accounts payable		75.3			53.4
Income tax receivable		(3.2	)		(2.2	)
Settlement agreement and related items		235.2			(929.7	)
Other liabilities		(65.1	)		(80.9	)
Net cash provided by (used in) operating activities		319.0			(932.5	)
Cash flows from investing activities:
Capital expenditures		(20.7	)		(28.4	)
Businesses acquired in purchase transactions, net of cash and cash equivalents acquired		(8.5	)		—
Proceeds from sales of property, equipment and other assets		25.3			1.4
Net cash used in investing activities		(3.9	)		(27.0	)
Cash flows from financing activities:
Net (payments of) proceeds from short-term borrowings		(41.4	)		603.4
Payments of long-term debt		(0.6	)		(200.4	)
Proceeds from long-term debt		2.7			—
Dividends paid on common stock		(27.5	)		(28.4	)
Acquisition of common stock for tax withholding obligations under our Omnibus stock plan and 2005 Contingent Stock Plan		(6.2	)		(2.6	)
Repurchases of common stock		(69.2	)		—
Other financing activities		—			—
Net cash (used in) provided by financing activities		(142.2	)		372.0
Effect of foreign currency exchange rate changes on cash and cash equivalents		40.8			8.2
Balance, beginning of period		322.6			992.4
Net change during the period		213.7			(579.3	)
Balance, end of period	$	536.3		$	413.1
Supplemental Cash Flow Information:
Interest payments, net of amounts capitalized	$	58.7		$	519.1
Income tax payments	$	23.8		$	14.7
Stock appreciation rights payments (less amounts included in restructuring payments)	$	3.7		$	14.2
Restructuring payments including associated costs	$	22.0		$	26.6
Non-cash items:
Transfers of shares of our common stock from treasury for our 2015 and 2014 profit-sharing plan contributions	$	36.7		$	32.0
Transfer of shares of our common stock as part of the funding of the Settlement agreement		—		1.8

We conduct substantially all of our business through three wholly-owned subsidiaries, Cryovac, Inc., Sealed Air Corporation (US) and Diversey, Inc. Throughout this report, when we refer to “Sealed Air,” the “Company,” “we,” “our,” or “us,” we are referring to Sealed Air Corporation and all of our subsidiaries, except where the context indicates otherwise.

Effective as of January 1, 2014, we changed our segment reporting structure. See Note 4, “Segments” for further information.

Our condensed consolidated financial statements include all of the accounts of the Company and our subsidiaries. We have eliminated all significant intercompany transactions and balances in consolidation. In management’s opinion, all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation of our condensed consolidated balance sheet as of March 31, 2015 and our condensed consolidated statements of operations for the three months ended March 31, 2015 and 2014 have been made. The results set forth in our condensed consolidated statements of operations for the three months ended March 31, 2015 and in our condensed consolidated statements of cash flows for the three months ended March 31, 2015 are not necessarily indicative of the results to be expected for the full year. All amounts are in millions, except per share amounts, and approximate due to rounding. Some prior period amounts have been reclassified to conform to the current year presentation. These reclassifications, individually and in the aggregate, had no impact on our condensed consolidated financial condition, results of operations and cash flows.

Our condensed consolidated financial statements were prepared in accordance with the interim reporting requirements of the SEC. As permitted under those rules, annual footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted. The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates.

We are responsible for the unaudited condensed consolidated financial statements and notes included in this report. As these are condensed financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 as filed with the SEC on February 27, 2015 (“2014 Form 10-K”) and with the information contained in other publicly-available filings with the SEC.

During the first quarter of 2015, we entered into an asset purchase agreement with NOVIPAX, a portfolio company of Atlas Holdings LLC, to sell our North American foam trays and absorbent pads business. During the three months ended March 31, 2015, the North American foam trays and absorbent pads business met the held for sale criteria and has been included as such in all periods presented in our condensed consolidated balance sheets. As a result, all applicable balances have been reclassified to held for sale. Refer to Note 3, “Divestiture” of the notes to condensed consolidated financial statements for further details.

During the fourth quarter of 2014, we changed the method of valuing our inventories that were valued using the last-in, first-out (“LIFO”) method to the first-in, first-out (“FIFO”) method. As a result of this accounting change, inventories, retained earnings, non-current deferred tax liability, net earnings (loss) available to common stockholders, basic earnings per share and diluted earnings per share, among other accounts, have been retrospectively changed.

As a result of the accounting change, all of our inventories are now determined using the FIFO method. We state inventories at the lower of cost or market.

In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) 2015-05, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement (“ASU 2015-05”). This ASU will help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement. It provides guidance about whether a cloud computing arrangement includes a software license. The amendments in ASU 2015-05 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. An entity can elect to adopt either prospectively to all arrangements entered into or materially modified after the effective date or retrospectively. We are currently in the process of evaluating this new standard update.

In April 2015, the FASB issued ASU 2015-03 Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). This ASU will simplify the presentation of debt issuance costs. It will require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amendments in ASU 2015-03 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. We are currently in the process of evaluating this new standard update.

In November 2014, the FASB issued ASU 2014-17, “Business Combinations (Topic 805): Pushdown Accounting (a consensus of the FASB Emerging Issues Task Force),” (“ASU 2014-17”). ASU 2014-17 provides an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. The amendments in ASU 2014-17 are effective November 18, 2014 and an acquired entity can make an election to apply the guidance to future change-in-control events or to its most recent change-in-control event. The effects of ASU 2014-17 will depend on any future events whereby we obtain control of an entity and elect to apply pushdown accounting.

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements—Going Concern (Subtopic 205-40),” (“ASU 2014-15”). ASU 2014-15 requires that for each annual and interim reporting period, an entity’s management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We do not expect the adoption of this standard update to have a material impact on our consolidated financial statements.

In June 2014, the FASB issued ASU 2014-12, “Compensation-Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period,” (“ASU 2014-12”). ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. Prior to the issuance of ASU 2014-12, U.S. GAAP did not contain explicit guidance on how to account for those share-based payments. Many reporting entities accounted for performance targets that could be achieved after the requisite service period as performance conditions that affect the vesting of the award and, therefore, did not reflect the performance target in the estimate of the grant-date fair value of the award. Other reporting entities treated those performance targets as non-vesting conditions that affected the grant-date fair value of the award. We currently treat performance targets that affect vesting as a performance condition and, as such, it is not included in the grant-date fair value. Therefore, the impact upon adoption would not be material to our consolidated financial position or results of operations. The amendments in ASU 2014-12 are effective for fiscal years and interim periods within those years, beginning after December 15, 2015. Earlier application is permitted.

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers,” (“ASU 2014-09”). Previous revenue recognition guidance in U.S. GAAP comprised broad revenue recognition concepts together with numerous revenue requirements for particular industries or transactions, which sometimes resulted in different accounting for economically similar transactions. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principal, five steps are required to be applied. In addition, ASU 2014-09 expands and enhances disclosure requirements which require disclosing sufficient information to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. This includes both qualitative and quantitative information. The amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted. On April 29, 2015 the FASB issued an exposure draft of a proposed ASU that would delay by one year the effective date of ASU 2014-09 and allow early adoption as of the original public entity effective date. We are currently in the process of evaluating this new standard update.

In April 2014, the FASB issued ASU 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity,” (“ASU 2014-08”). Under ASU 2014-08, only disposals representing a strategic shift in operations that have a major effect on the Company’s operations and financial results should be presented as discontinued operations. Additionally, ASU 2014-08 requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. The amendments in ASU 2014-08 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. However, ASU 2014-08 should not be applied to a component that is classified as held for sale before the effective date even if the component is disposed of after the effective date. Early adoption is permitted, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. We have adopted ASU 2014-08 for disposals occurring after January 1, 2015.

On February 11, 2015, we entered into an Asset Purchase Agreement with NOVIPAX, a portfolio company of Atlas Holdings LLC, to sell our North American foam trays and absorbent pads business for gross proceeds of $82 million, subject to purchase price adjustments. The decision to sell this business was based on managements' assessment that the business was becoming quickly commoditized and faced significant competitive pricing pressure and declining profit margins. The transaction closed on April 1, 2015; see Note 19, “Subsequent Events” for further information.

During the three months ended March 31, 2015, the North American foam trays and absorbent pads business met the held for sale criteria and has been included as such in all periods presented in our condensed consolidated balance sheets. The disposal of the North American foam trays and absorbent pads business did not qualify as a discontinued operation.

The carrying value of the major classes of assets and liabilities for the business was as follows:

	March 31,		December 31,
(In millions)	2015		2014
Assets:
Other receivables	$	-	$	0.1
Inventories		14.1		12.3
Prepaid expenses		0.1		0.1
Property and equipment, net		22.4		22.6
Goodwill		6.9		6.9
Assets held for sale	43.5			42.0

Liabilities:
Accrued liabilities	2.4		6.1
Liabilities held for sale	$	2.4	$	6.1

For the three months ended March 31, 2015 and March 31, 2014, the North American foam trays and absorbent pads businesses contributed approximately $53 million of net sales in each period; and $10 million and $9 million of pre-tax income, respectively, which excludes certain allocated costs, including corporate support services, for which the Company would normally include in measuring its performance. The North American foam trays and absorbent pads business was part of the Company’s Food Care division.

Effective as of January 1, 2014, we changed our segment reporting structure in order to reflect the way management now makes operating decisions and manages the growth and profitability of the business. This change corresponds with management’s current approach of allocating costs and resources and assessing the performance of our segments. We report our segment information in accordance with the provisions of Financial Accounting Standards Board Accounting Standards Codification Topic 280, “Segment Reporting,” (“FASB ASC Topic 280”). There has been no change in our total consolidated financial condition or results of operations previously reported as a result of the change in our segment structure. There were no changes to the reportable segment assets as a result of the change in segment reporting.

As a result, the Company’s new segment reporting structure consists of three reportable segments and an “Other” category and is as follows:

The Company’s Food Care, Diversey Care and Product Care segments are considered reportable segments under FASB ASC Topic 280. Our reportable segments are aligned with similar groups of products. Other includes Corporate and the Medical Applications and New Ventures businesses. The Medical Applications and New Ventures businesses were previously included in the Company’s “Other” category. Other includes certain costs that are not allocated to the reportable segments, primarily consisting of unallocated corporate overhead costs, including administrative functions and cost recovery variances not allocated to the reportable segments from global functional expenses.

Other also includes restructuring and other associated costs, expenses related to stock appreciation rights (“SARs”), which were issued in connection with the acquisition of Diversey in 2011, loss on debt redemptions and foreign currency exchange gains/losses related to Venezuelan subsidiaries and other one-time expenses and/or gains.

As of January 1, 2014, the Company also changed the segment performance measure in which management assesses segment performance and makes allocation decisions by segment from operating profit to Adjusted EBITDA. Adjusted EBITDA is defined as Earnings before Interest Expense, Taxes, Depreciation and Amortization, adjusted to exclude the impact of special items.

We allocate and disclose depreciation and amortization expense to our segments, although property and equipment, net is not allocated to the segment assets, nor is depreciation and amortization included in the segment performance metric Adjusted EBITDA. We also disclose restructuring and other charges and impairment of goodwill and other intangible assets by segment, although these items are not included in the segment performance metric Adjusted EBITDA since restructuring and other charges and impairment of goodwill and other intangible assets are categorized as special items as discussed above. The accounting policies of the reportable segments and Other are the same as those applied to the consolidated financial statements.

The changes in the Company’s segment structure and segment performance measure better provides management with information to assess segment performance and to make resource and allocation decisions, as the new segment structure and performance measure reflect the current management of our businesses. Accordingly, the new measure will also assist our investors by providing them with a better understanding of the segment so that the user can make a more informed decision about the Company, which is consistent with FASB ASC Topic 280.

The following tables show net sales and Adjusted EBITDA by our segment reporting structure:

	Three Months Ended
	March 31,
(In millions)	2015			2014
Net Sales:
Food Care	$	879.8		$	904.3
As a % of Total Company net sales		50.4	%		49.5	%
Diversey Care		467.9			505.1
As a % of Total Company net sales		26.8	%		27.6	%
Product Care		377.1			393.8
As a % of Total Company net sales		21.6	%		21.5	%
Total Reportable Segments Net Sales		1,724.8			1,803.2
Other		21.6			24.5
Total Company Net Sales	$	1,746.4		$	1,827.7

	Three Months Ended
	March 31,
(In millions)	2015			2014⁽¹⁾
Adjusted EBITDA:
Food Care	$	190.5		$	159.0
Adjusted EBITDA Margin		21.7	%		17.6	%
Diversey Care		41.0			44.4
Adjusted EBITDA Margin		8.8	%		8.8	%
Product Care		75.6			69.1
Adjusted EBITDA Margin		20.0	%		17.5	%
Total Reportable Segments Adjusted EBITDA		307.1			272.5
Other		(22.9	)		(21.8	)
Non-U.S. GAAP Total Company Adjusted EBITDA	$	284.2		$	250.7
Adjusted EBITDA Margin		16.3	%		13.7	%

The following table shows a reconciliation of Total Company Adjusted EBITDA to net earnings available to common stockholders:

	Three Months Ended
	March 31,
(In millions)	2015			2014⁽¹⁾
Total Company Adjusted EBITDA	$	284.2		$	250.7
Depreciation and amortization⁽²⁾		(73.1	)		(82.8	)
Special items:
Accelerated depreciation of non-strategic assets related to restructuring programs		0.6			—
Restructuring and other charges⁽³⁾		(12.7	)		(6.1	)
Other restructuring associated costs included in cost of sales and selling general and administrative expenses		(6.4	)		(4.6	)
Relocation costs included in cost of sales and selling, general and administrative expenses		(2.6	)		—
Gain from sale of building in connection with relocation		3.5			—
SARs		(2.9	)		(0.5	)
Integration related costs		(0.7	)		(0.9	)
Foreign currency exchange net gains (losses) related to Venezuelan subsidiaries		0.8			(15.0	)
Gain from Claims Settlement in 2014 and related costs		—			21.1
Other expense, net		(0.9	)		(2.3	)
Interest expense		(58.5	)		(78.5	)
Income tax provision		34.1			10.2
Net earnings available to common stockholders	$	97.2		$	70.9

The following table details our interest cost capitalized and depreciation and amortization expense for property and equipment.

The following table shows our goodwill balances by our segment reporting structure. We review goodwill for impairment on a reporting unit basis annually during the fourth quarter of each year and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. As of March 31, 2015, we did not identify any changes in circumstances that would indicate the carrying value of goodwill may not be recoverable.

(In millions)	Food Care			Diversey Care			Product Care			Other			Total
Gross Carrying Value at December 31, 2014⁽¹⁾	$	812.8		$	1,900.8		$	1,371.2		$	4.8		$	4,089.6
Acquisition		—			15.8			—			—			15.8
Dispositions		—			—			(0.8	)		—			(0.8	)
Currency translation		(5.8	)		(49.6	)		(0.3	)		(3.3	)		(59.0	)
Gross Carrying Value at March 31, 2015		807.0			1,867.0			1,370.1			1.5			4,045.6
Accumulated impairment		(208.0	)		(883.0	)		—			—			(1,091.0	)
Carrying Value at March 31, 2015⁽¹⁾	$	599.0		$	984.0		$	1,370.1		$	1.5		$	2,954.6

The following tables summarize our identifiable intangible assets with definite and indefinite useful lives. As of March 31, 2015, there were no impairment indicators present.

	March 31, 2015										December 31, 2014
	Gross										Gross
	Carrying		Accumulated			Accumulated					Carrying		Accumulated			Accumulated
(In millions)	Value		Amortization			Impairment			Net		Value		Amortization			Impairment			Net
Customer relationships	$	857.5	$	(215.0	)	$	(148.9	)	$	493.6	$	890.8	$	(210.8	)	$	(148.9	)	$	531.1
Trademarks and trade names		1.3		(0.3	)		—			1.0		1.3		(0.2	)		—			1.1
Technology		274.1		(170.2	)		(22.2	)		81.7		266.4		(167.0	)		(22.2	)		77.2
Contracts		38.3		(28.2	)		—			10.1		40.6		(28.9	)		—			11.7
Total intangible assets with definite lives		1,171.2		(413.7	)		(171.1	)		586.4		1,199.1		(406.9	)		(171.1	)		621.1
Trademarks and trade⁽¹⁾ names with indefinite lives		881.3		—			(630.2	)		251.1		881.3		—			(630.2	)		251.1
Total⁽²⁾	$	2,052.5	$	(413.7	)	$	(801.3	)	$	837.5	$	2,080.4	$	(406.9	)	$	(801.3	)	$	872.2

⁽¹⁾ The intangible assets include $251 million of trademarks and trade names that we have determined to have indefinite useful lives, primarily acquired in connection with the acquisition of Diversey.

⁽²⁾ Excludes North American foam trays and absorbent pads business intangible assets. Refer to Note 3, “Divestiture” of the notes to condensed consolidated financial statements for further details.

The following table shows the remaining estimated future amortization expense at March 31, 2015.

We and a group of our U.S. operating subsidiaries maintain an accounts receivable securitization program under which they sell eligible U.S. accounts receivable to an indirectly wholly-owned subsidiary that was formed for the sole purpose of entering into this program. The wholly-owned subsidiary in turn may sell an undivided fractional ownership interest in these receivables with two banks and issuers of commercial paper administered by these banks. The wholly-owned subsidiary retains the receivables it purchases from the operating subsidiaries. Any transfers of fractional ownership interests of receivables under the U.S. receivables securitization program to the two banks and issuers of commercial paper administered by these banks are considered secured borrowings with pledge of collateral and will be classified as short-term borrowings on our condensed consolidated balance sheet. The net trade receivables that served as collateral for these borrowings are reclassified from trade receivables, net to prepaid expenses and other current assets on the condensed consolidated balance sheet.

As of March 31, 2015, the maximum purchase limit for receivable interests was $100 million, subject to the availability limits described below.

The amounts available from time to time under this program may be less than $100 million due to a number of factors, including but not limited to our credit ratings, trade receivable balances, the creditworthiness of our customers and our receivables collection experience. During the three months ended March 31, 2015, the level of eligible assets available under the program was lower than $100 million primarily due to certain required reserves against our receivables. As a result, the amount available to us under the program was $75 million at March 31, 2015. Although we do not believe restrictions under this program presently materially restrict our operations, if an additional event occurs that triggers one of these restrictive provisions, we could experience a further decline in the amounts available to us under the program or termination of the program.

This program expires annually in September and is renewable. The program was renewed in September 2014 for an additional year and the program size was reduced from $125 million to $100 million.

We and a group of our European subsidiaries maintain an accounts receivable securitization program with a special purpose vehicle, or SPV, two banks and issuers of commercial paper administered by these banks. The European program is structured to be a securitization of certain trade receivables that are originated by certain of our European subsidiaries. We do not have an equity interest in the SPV. However, since we are considered the primary beneficiary of the SPV, it meets the criteria to be classified as a variable interest entity and is included in our condensed consolidated financial statements. Any activity between the participating subsidiaries and the SPV is eliminated in consolidation. The SPV borrows funds from the banks to fund its acquisition of the receivables and provides the banks with a first priority perfected security interest in the accounts receivable. Loans from the banks to the SPV will be classified as short-term borrowings on our condensed consolidated balance sheet. The net trade receivables that served as collateral for these borrowings are reclassified from trade receivables, net to prepaid expenses and other current assets on the condensed consolidated balance sheet.

As of March 31, 2015, the maximum purchase limit for receivable interests was €110 million, ($120 million equivalent at March 31, 2015) subject to availability limits. The terms and provisions of this program are similar to our U.S.-program discussed above. As of March 31, 2015, the amount available under this program was €99 million ($108 million equivalent as of March 31, 2015).

This program expires annually in February and is renewable. The program was renewed in February 2015 and the maximum purchase limit was raised to €110 million.

At March 31, 2015, there were no borrowings outstanding under our U.S. program or European program. We continue to service the trade receivables supporting the programs, and the banks are permitted to re-pledge this collateral. Total interest expense related to the use of these programs was less than $1 million for the three months ended March 31, 2015.

Under limited circumstances, the banks and the issuers of commercial paper can end purchases of receivables interests before the above expiration dates. A failure to comply with debt leverage or various other ratios related to our receivables collection experience could result in termination of the receivables programs. We were in compliance with these ratios at March 31, 2015.

As of December 31, 2014, the total amount of borrowings under our U.S. program was $36 million and there were no amounts outstanding under the European program.

	Three Months Ended March 31,
	2015										2014
(In millions)	IOP			EQIP			Fusion		Total		IOP		EQIP		Total
Other associated costs	$	1.9		$	3.0		$	3.0	$	7.9	$	1.4	$	2.7	$	4.1
Restructuring charges		(0.3	)		(6.9	)		19.9		12.7		1.3		4.8		6.1
Total	$	1.6		$	(3.9	)	$	22.9	$	20.6	$	2.7	$	7.5	$	10.2

On December 18, 2014, the Board of Directors of the Company approved a new restructuring plan (the “Fusion Program” or the “Plan”), which consists of a portfolio of restructuring projects across all of our divisions as part of our transformation of Sealed Air Corporation into a knowledge-based company, including reduction in headcount and consolidation and relocation of certain facilities and offices.

The Company currently estimates that it will incur aggregate costs of approximately $395 million to $405 million in connection with the implementation of this Plan which compares to previously reported estimates of $275 million to $285 million. The increase represents our recent decision to build and own the Campus in Charlotte, North Carolina, rather than lease. The cost of the Charlotte campus is estimated to be approximately $120 million. The net cash cost of the Plan is now expected to be in the range of $330 million to $340 million. The costs associated with the Plan, the majority of which are expected to be incurred between 2015 and 2017, will primarily consist of (i) a reduction in headcount through reorganization and integration, including severance and termination benefits for employees, expected to be approximately $115 million to $120 million, and (ii) other costs associated with the Plan, primarily relating to the building costs of the Charlotte campus, rationalization, consolidation and relocation of certain portions of our global supply chain and other facilities and offices, expected to be approximately $280 million to $285 million. Included in the total cash costs, the Company anticipates approximately $175 million to $185 million of capital expenditures related to the Plan, including the building of the Charlotte campus, of which the majority is expected to be incurred between 2015 and 2016.

The other associated costs included in the table above primarily consist of consulting and other costs incurred in connection with the project relocation efforts, which were included in selling, general and administrative expenses on the consolidated statements of operations for the year ended December 31, 2014. The restructuring charges included in the table above primarily consist of termination and benefit costs.

On July 23, 2014, we announced that we will be establishing a new global headquarters in Charlotte, North Carolina. We will relocate the headquarters for our divisions, research and development facilities, and corporate offices. Within the next three years, we anticipate approximately 1,300 jobs will be relocated to Charlotte from our former corporate headquarters in Elmwood Park, New Jersey; and facilities in Saddle Brook, New Jersey; Danbury, Connecticut; Racine, Wisconsin; and, Duncan and Greenville, South Carolina. We will also relocate a small number of jobs from other locations.

On August 31, 2014, in connection with our relocation efforts, we signed an agreement for purchase and sale relating to our facility located in Racine, Wisconsin. As of December 31, 2014, the building and certain related assets met the criteria of assets held for sale classification. Accordingly, we reclassified $26 million from property, plant and equipment to assets held for sale as of December 31, 2014. The sale closed in January 2015. In addition, we leased back the building until December 2015 but have the option to exit the lease earlier. The final sales price was $30 million, of which net proceeds of $24 million were received as part of the closing along with a $6 million unsecured promissory note to be paid once we exit the facility. We recorded a pre-tax gain on the sale of approximately $3 million in January 2015.

The restructuring accrual, spending and other activity for the three months ended March 31, 2015 and the accrual balance remaining at March 31, 2015 related to this program were as follows (in millions):

The accrual and accrual adjustments includes a reclassification adjustment of $13 million to transfer two projects from the EQIP Program to the Fusion Program in order to better match the projects to the program synergies. There is no net impact to the financial statements resulting from the reclassification adjustment.

Cumulative cash payments made in connection with this program, including associated costs through March 31, 2015, were $7 million. We expect to pay $22 million of the accrual balance remaining at March 31, 2015 within the next twelve months. This amount is included in accrued restructuring costs on the condensed consolidated balance sheet at March 31, 2015. The majority of the remaining accrual of $2 million is expected to be paid in 2016. This amount is included in other non-current liabilities on our condensed consolidated balance sheet at March 31, 2015.

In May 2013, we announced the commencement of EQIP, which is an initiative to deliver meaningful cost savings and network optimization. The costs associated with this plan consist primarily of (i) a reduction in headcount, which is expected to be approximately 750-900 employees and other costs associated with divisional realignment and connected profitability improvement programs, including severance and termination benefits for employees, expected to be approximately $105 million to $120 million, and (ii) costs and capital expenditures associated with incremental supply chain network optimization projects, including facility relocation and closures, expected to be approximately $85 million to $90 million. We currently estimate that we will incur total costs of approximately $190 million to $210 million in connection with implementation of this plan, including capital expenditures of approximately $50 million to $55 million. The plan is expected to be substantially completed by the end of 2016.

The other associated costs included in the table above primarily consist of consulting and rebranding costs incurred in connection with the rebranding of the Company and its divisions, which were included in selling, general and administrative expenses on the condensed consolidated statements of operations for the three months ended March 31, 2015. The restructuring charges included in the table above primarily consist of termination and benefit costs.

Cumulative cash payments made in connection with this program, including associated costs through March 31, 2015, were $125 million. We expect to pay all of the $23 million accrual balance remaining at March 31, 2015 within the next twelve months. This amount is included in accrued restructuring costs on the condensed consolidated balance sheet at March 31, 2015.

Capital expenditures related to this program were $2 million in the three months ended March 31, 2015 and $3 million in the three months ended March 31, 2014. Capital expenditures primarily relate to supply chain network optimization.

In December 2011, we initiated a restructuring program associated with the integration of Diversey’s business following our acquisition of Diversey on October 3, 2011. The program primarily consists of (i) reduction in headcount, (ii) consolidation of facilities, (iii) supply chain network optimization, and (iv) certain other capital expenditures. This program was substantially completed as of the end of 2014.

The other associated costs in the table above primarily consist of consulting fees included in selling, general and administrative expenses on the condensed consolidated statement of operations.

Cumulative cash payments made in connection with this program, including associated costs through March 31, 2015, were $225 million. We expect to pay all of the $8 million accrual balance as of March 31, 2015 within the next twelve months. This amount is included in accrued restructuring costs on the condensed consolidated balance sheet at March 31, 2015.

Capital expenditures related to this program were less than $1 million in the three months ended March 31, 2015 and March 31, 2014. Capital expenditures mainly relate to facilities and supply chain network optimization.

Our total debt outstanding consisted of the amounts set forth on the following table:

	March 31,		December 31,
(In millions)	2015		2014
Short-term borrowings ⁽¹⁾	$	85.2	$	130.4
Current portion of long-term debt		1.3		1.1
Total current debt		86.5		131.5
Term Loan A Facility due July 2017, less unamortized lender fees of $0.3 in 2015 and $0.3 in 2014⁽²⁾		249.7		249.7
Term Loan A Facility due July 2019, less unamortized lender fees of $10.0 in 2015 and $10.6 in 2014⁽²⁾		1,106.9		1,129.4
6.50% Senior Notes due December 2020		428.0		428.1
8.375% Senior Notes due September 2021		750.0		750.0
4.875% Senior Notes due December 2022		425.0		425.0
5.25% Senior Notes due April 2023		425.0		425.0
5.125% Senior Notes due December 2024		425.0		425.0
6.875% Senior Notes due July 2033, less unamortized discount of $1.3 in 2015 and $1.3 in 2014		448.7		448.7
Other		3.5		1.6
Total long-term debt, less current portion		4,261.8		4,282.5
Total debt⁽³⁾	$	4,348.3	$	4,414.0

The following table summarizes our available lines of credit and committed and uncommitted lines of credit, including the Revolving Credit Facility discussed above, and the amounts available under our accounts receivable securitization programs. We are not subject to any material compensating balance requirements in connection with our lines of credit.

Each issue of our outstanding senior notes imposes limitations on our operations and those of specified subsidiaries. The Amended Credit Facility contains customary affirmative and negative covenants for credit facilities of this type, including limitations on our indebtedness, liens, investments, restricted payments, mergers and acquisitions, dispositions of assets, transactions with affiliates, amendment of documents and sale leasebacks, and a covenant specifying a maximum permitted ratio of Consolidated Net Debt to Consolidated EBITDA (as defined in the Credit Facility). We were in compliance with the above financial covenants and limitations at March 31, 2015.

We report all derivative instruments on our condensed consolidated balance sheets at fair value and establish criteria for designation and effectiveness of transactions entered into for hedging purposes.

As a large global organization, we face exposure to market risks, such as fluctuations in foreign currency exchange rates and interest rates. To manage the volatility relating to these exposures, we enter into various derivative instruments from time to time under our risk management policies. We designate derivative instruments as hedges on a transaction basis to support hedge accounting. The changes in fair value of these hedging instruments offset in part or in whole corresponding changes in the fair value or cash flows of the underlying exposures being hedged. We assess the initial and ongoing effectiveness of our hedging relationships in accordance with our policy. We do not purchase, hold or sell derivative financial instruments for trading purposes. Our practice is to terminate derivative transactions if the underlying asset or liability matures or is sold or terminated, or if we determine the underlying forecasted transaction is no longer probable of occurring.

The primary purposes of our cash flow hedging activities are to manage the potential changes in value associated with the amounts receivable or payable on equipment and raw material purchases that are denominated in foreign currencies in order to minimize the impact of the changes in foreign currencies. We record gains and losses on foreign currency forward contracts qualifying as cash flow hedges in other comprehensive income to the extent that these hedges are effective and until we recognize the underlying transactions in net earnings, at which time we recognize these gains and losses in other expense, net, on our condensed consolidated statements of operations.

Net unrealized after tax gains (losses) related to these contracts that were included in other comprehensive income were $1 million for the three months ended March 31, 2015 and $2 million for the three months ended March 31, 2014. The unrealized amounts in other comprehensive income will fluctuate based on changes in the fair value of open contracts during each reporting period.

Our subsidiaries have foreign currency exchange exposure from buying and selling in currencies other than their functional currencies. The primary purposes of our foreign currency hedging activities are to manage the potential changes in value associated with the amounts receivable or payable on transactions denominated in foreign currencies and to minimize the impact of the changes in foreign currencies related to foreign currency denominated interest-bearing intercompany loans and receivables and payables. The changes in fair value of these derivative contracts are recognized in other income, net, on our condensed consolidated statements of operations and are largely offset by the remeasurement of the underlying foreign currency denominated items indicated above. These contracts generally have original maturities of less than 12 months.

From time to time, we may use interest rate swaps to manage our fixed and floating interest rates on our outstanding indebtedness.

At March 31, 2015, we had no outstanding interest rate swaps. At March 31, 2014, we had $100 million notional amount of outstanding interest rate swaps, which did not materially impact our condensed consolidated results of operations or financial position.

In 2014, in connection with exercising the $100 million delayed draw under the senior secured credit facility, we entered into a series of interest rate and currency swaps in a notional amount of $100 million. These swaps convert the U.S. dollar denominated variable rate obligation under the credit facility into a fixed Brazilian real denominated obligation. The delayed draw and the interest rate and currency swaps are used to fund expansion and general corporate purposes of our Brazilian subsidiaries.

In March 2015, we entered into a series of cross currency swaps with a combined notional amount of $425 million, hedging a portion of the net investment in a certain European subsidiary against fluctuations in foreign exchange rates. For derivative instruments that are designated and qualify as hedges of net investments in foreign operations, settlements and changes in fair values of the derivative instruments are recognized in currency translation adjustment, a component of accumulated other comprehensive loss, net of taxes, to offset the changes in the values of the net investments being hedged. Any portion of the net investment hedge that is determined to be ineffective is recorded in other income, net on the condensed consolidated statements of operations.

We may use other derivative instruments from time to time, such as foreign exchange options to manage exposure to foreign exchange rates and to access to international financing transactions. These instruments can potentially limit foreign exchange exposure by swapping borrowings denominated in one currency for borrowings denominated in another currency. At March 31, 2015 and 2014, we had no foreign exchange options outstanding.

See Note 12, “Fair Value Measurements and Other Financial Instruments,” for a discussion of the inputs and valuation techniques used to determine the fair value of our outstanding derivative instruments.

The following table details the fair value of our derivative instruments included on our condensed consolidated balance sheets.

	Fair Value of Asset				Fair Value of (Liability)
	Derivatives				Derivatives
	March 31,		December 31,		March 31,			December 31,
(In millions)	2015		2014		2015			2014
Derivatives designated as hedging instruments:
Foreign currency forward contracts (cash flow hedges)	$	5.5	$	4.3	$	(1.9	)	$	(0.4	)
Interest rate and currency swaps (cash flow hedges)		31.9		17.8		—			—
Cross-currency swaps (net investment hedges)		—		—		(13.0	)		—
Derivatives not designated as hedging instruments:
Foreign currency forward contracts		64.6		41.3		(77.1	)		(67.6	)
Total	$	102.0	$	63.4	$	(92.0	)	$	(68.0	)

Short-term asset derivatives and liability derivatives are included in prepaid expenses and other current assets, or other current liabilities, respectively. Long-term asset derivatives and liability derivatives are included in other non-current assets or other non-current liabilities, respectively.

The following table details the effect of our derivative instruments on our condensed consolidated statements of operations.

	Amount of Gain (Loss)
	Recognized on Derivatives
	in Earnings
	Three Months Ended
	March 31,
(In millions)	2015		2014
Derivatives designated as hedging instruments:
Foreign currency forward contracts (cash flow hedges)⁽¹⁾	$	0.8	$	2.3
Interest rate and currency swaps (cash flow hedges)⁽²⁾		15.1		—
Treasury locks (cash flow hedges)⁽³⁾		0.1		0.1
Sub-total cash flow hedges		16.0		2.4
Interest rate swaps (fair value hedges)		0.1		0.5
Derivatives not designated as hedging instruments:
Foreign currency forward contracts		32.0		(3.1	)
Total	$	48.1	$	(0.2	)

In determining fair value of financial instruments, we utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and consider counterparty credit risk in our assessment of fair value. We determine fair value of our financial instruments based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

The following table details the fair value hierarchy of our financial instruments:

	March 31, 2015
(In millions)	Total Fair Value			Level 1		Level 2			Level 3
Cash equivalents	$	120.0		$	—	$	120.0		$	—
Derivative financial instruments net asset (liability):
Foreign currency forward contracts	$	(8.9	)	$	—	$	(8.9	)	$	—
Interest rate and currency swaps	$	31.9		$	—	$	31.9		$	—
Cross-currency swaps	$	(13.0	)	$	—	$	(13.0	)	$	—

	December 31, 2014
(In millions)	Total Fair Value			Level 1		Level 2			Level 3
Cash equivalents	$	64.7		$	—	$	64.7		$	—
Derivative financial instruments net asset (liability):
Interest rate swaps	$	—		$	—	$	—		$	—
Foreign currency forward contracts	$	(22.4	)	$	—	$	(22.4	)	$	—
Interest rate and currency swaps	$	17.8		$	—	$	17.8		$	—

Our cash equivalents at March 31, 2015 and December 31, 2014 consisted of commercial paper (fair value determined using Level 2 inputs). Since these are short-term highly liquid investments with original maturities of three months or less at the date of purchase, they present negligible risk of changes in fair value due to changes in interest rates.

Our foreign currency forward contracts are recorded at fair value on our condensed consolidated balance sheets using an income approach valuation technique based on observable market inputs (Level 2).

Observable market inputs used in the calculation of the fair value of foreign currency forward contracts include foreign currency spot and forward rates obtained from an independent third party market data provider. In addition, other pricing data quoted by various banks and foreign currency dealers involving identical or comparable instruments are included.

Counterparties to these foreign currency forward contracts are rated at least A- by Standard & Poor’s and Baa2 by Moody’s. Credit ratings on some of our counterparties may change during the term of our financial instruments. We closely monitor our counterparties’ credit ratings and, if necessary, will make any appropriate changes to our financial instruments. The fair value generally reflects the estimated amounts that we would receive or pay to terminate the contracts at the reporting date.

The following financial instruments are recorded at fair value or at amounts that approximate fair value: (1) trade receivables, net, (2) certain other current assets, (3) accounts payable and (4) other current liabilities. The carrying amounts reported on our condensed consolidated balance sheets for the above financial instruments closely approximate their fair value due to the short-term nature of these assets and liabilities.

Other liabilities that are recorded at carrying value on our condensed consolidated balance sheets include our senior notes. We utilize a market approach to calculate the fair value of our senior notes. Due to their limited investor base and the face value of some of our senior notes, they may not be actively traded on the date we calculate their fair value. Therefore, we may utilize prices and other relevant information generated by market transactions involving similar securities, reflecting U.S. Treasury yields to calculate the yield to maturity and the price on some of our senior notes. These inputs are provided by an independent third party and are considered to be Level 2 inputs.

We derive our fair value estimates of our various other debt instruments by evaluating the nature and terms of each instrument, considering prevailing economic and market conditions, and examining the cost of similar debt offered at the balance sheet date. We also incorporated our credit default swap rates and currency specific swap rates in the valuation of each debt instrument, as applicable.

These estimates are subjective and involve uncertainties and matters of significant judgment, and therefore we cannot determine them with precision. Changes in assumptions could significantly affect our estimates.

The table below shows the carrying amounts and estimated fair values of our total debt:

	March 31, 2015				December 31, 2014
	Carrying		Fair		Carrying		Fair
(In millions)	Amount		Value		Amount		Value
Term Loan A Facility due July 2017	$	249.7	$	249.7	$	249.7	$	249.7
Term Loan A Facility due July 2019		1,106.9		1,106.9		1,129.4		1,129.4
6.50% Senior Notes due December 2020		428.0		476.6		428.1		469.7
8.375% Senior Notes due September 2021		750.0		843.9		750.0		843.3
4.875% Senior Notes due December 2022		425.0		434.0		425.0		423.3
5.25% Senior Notes due April 2023		425.0		445.1		425.0		429.6
5.125% Senior Notes due December 2024		425.0		440.4		425.0		428.5
6.875% Senior Notes due July 2033		448.7		474.8		448.7		462.9
Other foreign loans		87.2		87.1		73.9		73.8
Other domestic loans⁽¹⁾		2.8		3.2		59.2		59.2
Total debt	$	4,348.3	$	4,561.7	$	4,414.0	$	4,569.4

As of March 31, 2015, we did not have any non–financial assets and liabilities that were carried at fair value on a recurring basis in the condensed consolidated financial statements or for which a fair value measurement was required. Included among our non-financial assets and liabilities that are not required to be measured at fair value on a recurring basis are inventories, net property and equipment, goodwill, intangible assets and asset retirement obligations.

Financial instruments, including derivatives, expose us to counterparty credit risk for nonperformance and to market risk related to changes in interest or currency exchange rates. We manage our exposure to counterparty credit risk through specific minimum credit standards, establishing credit limits, diversification of counterparties, and procedures to monitor concentrations of credit risk.

We do not expect any of our counterparties in derivative transactions to fail to perform as it is our policy to have counterparties to these contracts that are rated at least BBB- or higher by Standard & Poor’s and Baa3 or higher by Moody’s. Nevertheless, there is a risk that our exposure to losses arising out of derivative contracts could be material if the counterparties to these agreements fail to perform their obligations. We will replace counterparties if a credit downgrade is deemed to increase our risk to unacceptable levels.

We regularly monitor the impact of market risk on the fair value and cash flows of our derivative and other financial instruments considering reasonably possible changes in interest and currency exchange rates and restrict the use of derivative financial instruments to hedging activities. We do not use derivative financial instruments for trading or other speculative purposes and do not use leveraged derivative financial instruments.

We continually monitor the creditworthiness of our diverse base of customers to which we grant credit terms in the normal course of business and generally do not require collateral. We consider the concentrations of credit risk associated with our trade accounts receivable to be commercially reasonable and believe that such concentrations do not leave us vulnerable to significant risks of near-term severe adverse impacts. The terms and conditions of our credit sales are designed to mitigate concentrations of credit risk with any single customer. Our sales are not materially dependent on a single customer or a small group of customers.

Our effective income tax rate for the three months ended March 31, 2015 was 25.9%. Our effective income tax rate benefited from a favorable earnings mix with earnings in jurisdictions with low tax rates.

Our effective income tax rate for the three months ended March 31, 2014 was 12.6%. Our effective income tax rate benefited from a favorable earnings mix with earnings in jurisdictions with low tax rates. In addition, our tax rate benefited from certain favorable discrete items totaling approximately $13 million, including $7 million from a favorable tax settlement and approximately $6 million from the release of reserves related to the statute of limitations and a successful judicial verdict. The favorable factors were partially offset by the $15 million foreign currency exchange losses related to Venezuelan subsidiaries with no tax benefit and the lapse of various U.S. tax provisions (the “Extenders”), including the research and development credit and certain foreign provisions.

During the three months ended March 31, 2015, we did not make a material change to our unrecognized tax benefits. We have not changed our policy with regard to the reporting of penalties and interest related to unrecognized tax benefits.

Refer to Part II, Item 8, Note 17, “Commitments and Contingencies” to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 for a description of the Settlement agreement (as defined therein) and related matters. In the first quarter of 2014 we recorded a gain of $21 million related to the Settlement agreement.

We are subject to loss contingencies resulting from environmental laws and regulations, and we accrue for anticipated costs associated with investigatory and remediation efforts when an assessment has indicated that a loss is probable and can be reasonably estimated. These accruals are not reduced by potential insurance recoveries, if any. We do not believe that it is reasonably possible that our liability in excess of the amounts that we have accrued for environmental matters will be material to our condensed consolidated financial condition or results of operations. Environmental liabilities are reassessed whenever circumstances become better defined or remediation efforts and their costs can be better estimated.

We evaluate these liabilities periodically based on available information, including the progress of remedial investigations at each site, the current status of discussions with regulatory authorities regarding the methods and extent of remediation and the apportionment of costs among potentially responsible parties. As some of these issues are decided (the outcomes of which are subject to uncertainties) or new sites are assessed and costs can be reasonably estimated, we adjust the recorded accruals, as necessary. We believe that these exposures are not material to our condensed consolidated financial condition or results of operations. We believe that we have adequately reserved for all probable and estimable environmental exposures.

We are a party to many contracts containing guarantees and indemnification obligations. These contracts primarily consist of:

On May 25, 2010, one of our Italian subsidiaries received a demand from the Italian Ministry of Economic Development (the “Ministry”) for the total repayment of grant monies paid to two of our former subsidiaries in the amount of €5 million. The grant monies had previously been certified as payable by the Italian authorities and the grant process was finalized and closed in 2006. We acquired the former subsidiaries in September 2001 as part of an acquisition. The substance of the repayment demand is that the former owners of the subsidiaries made fraudulent claims and used fraudulent documents to support their grant application prior to our acquisition. There is no suggestion that we or our Italian subsidiary were directly involved in the grant process, but as purchaser of the two companies, the Ministry is seeking repayment from our Italian subsidiary. Our Italian subsidiary submitted a total denial of liability in regard to this matter on June 30, 2010. A hearing on the merits was held on July 3, 2014 and in mid-September; our subsidiary was advised that the demand for repayment of €10 million was upheld. Accordingly, we recorded a current liability and corresponding charge of $14 million related to this matter in 2014. The liability ($12 million equivalent at March 31, 2015 with accrued interest) is included in other current liabilities on the condensed consolidated balance sheets and the charge is included in selling, general and administrative expenses on the condensed consolidated statements of operations. The charge is treated as a special item and included in Corporate in the “Other” category for segment reporting purposes. In mid-December, 2014 we learned our application to suspend enforcement of the judgment pending appeal had been declined. A final hearing on the merits is expected to be heard in two to three years.

On August 9, 2007, we announced that our Board of Directors had approved a share repurchase program authorizing us to repurchase in the aggregate up to 20 million shares of our outstanding common stock. This program has no set expiration date. This program replaced our prior share repurchase program, which we terminated at that time. Refer to Part II, Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds” for further information.

During the three months ended March 31, 2015, we repurchased 1,014,147 shares for approximately $44 million under a share trading plan we entered into with two of our brokers in accordance with Rule 10b5-1 of the Securities Act of 1933, as amended, and pursuant to the share repurchase program previously approved by our Board of Directors. The Company funded the stock repurchase with cash and cash equivalents.

Additionally, in March 2015, the Company entered into an accelerated shares repurchase agreement (“ASR”) with a third-party financial institution to repurchase $25 million of the Company’s common stock. Under the agreement, the Company paid $25 million to the financial institution and received an initial delivery of 433,181 shares at an aggregate cost of $20 million, with an average price per share of $46.17. These shares were included in treasury stock in the accompanying condensed consolidated balance sheet at March 31, 2015. The remaining $5 million was included in additional paid in capital in the accompanying condensed consolidated balance sheets at March 31, 2015. The ASR agreement will be settled during the second quarter of 2015. The final number of shares delivered upon settlement of the March 2015 ASR agreement will be determined with reference to the average price of the Company’s common stock over the term of the ASR agreement. These repurchases were also made under the share repurchase program approved by our Board of Directors referenced above.

On February 17, 2015, our Board of Directors declared a quarterly cash dividend of $0.13 per common share, or $28 million, which was paid on March 20, 2015 to stockholders of record at the close of business on March 6, 2015.

The dividend payments discussed above are recorded as reductions to cash and cash equivalents and retained earnings on our condensed consolidated balance sheets. Our credit facility and our notes contain covenants that restrict our ability to declare or pay dividends. However, we do not believe these covenants are likely to materially limit the future payment of quarterly cash dividends on our common stock. From time to time, we may consider other means of returning value to our stockholders based on our consolidated financial condition and results of operations. There is no guarantee that our Board of Directors will declare any further dividends.

In connection with the acquisition of Diversey, Sealed Air exchanged Diversey’s cash-settled stock appreciation rights and stock options that were unvested as of May 31, 2011 and unexercised at October 3, 2011 into cash-settled stock appreciation rights based on Sealed Air common stock. At March 31, 2015, all outstanding SARs are fully vested.

Since these SARs are settled in cash, the amount of the related future expense will fluctuate based on the forfeiture activity and the changes in the assumptions used in a Black-Scholes valuation model which includes Sealed Air’s stock price, risk-free interest rates, expected volatility and a dividend yield. In addition, once vested, the related expense will continue to fluctuate due to the changes in the assumptions used in the Black-Scholes valuation model for any SARs that are not exercised until their respective expiration dates, the last of which is currently in March 2021.

We recognized SARs expense of $3 million in the three months ended March 31, 2015 related to SARs that were granted to Diversey employees who remained employees as of March 31, 2015. We recognized SARs expense of $1 million in the three months ended March 31, 2014 related to SARs that were granted to Diversey employees who remained employees as of March 31, 2014. Cash payments due to the exercise of these SARs were $4 million in the three months ended March 31, 2015 and $14 million in the three months ended March 31, 2014. As of March 31, 2015, the remaining liability for these SARs was $19 million and is included in other current liabilities on our condensed consolidated balance sheet.

We did not recognize any SARs-related restructuring expense in the three months ended March 31, 2015 and there was no remaining liability for SARs included in the restructuring programs as of March 31, 2015. We recognized SARs-related restructuring expense of less than $1 million in the three months ended March 31, 2014 that were part of the termination and benefit costs for employees under the IOP.

We record share-based incentive compensation expense in selling, general and administrative expenses and cost of sales on our condensed consolidated statements of operations with a corresponding credit to additional paid-in capital within stockholders’ equity based on the fair value of the share-based incentive compensation awards at the date of grant. We recognize an expense or credit reflecting the straight-line recognition, net of estimated forfeitures, of the expected cost of the program. For the various PSU awards programs described below, the cumulative amount accrued to date is adjusted up or down to the extent the expected performance against the targets has improved or worsened.

As part of our long term incentive program initially adopted in 2008, during the first 90 days of each year, the Organization and Compensation Committee of our Board of Directors, or Compensation Committee, has approved PSU awards for our executive officers and other selected key executives, which include for each officer or executive a target number of shares of common stock and performance goals and measures that will determine the percentage of the target award that is earned following the end of the performance period. Following the end of the performance period, participants will also receive a cash payment in the amount of the dividends (without interest) that would have been paid during the performance period on the number of shares that they have earned. We have accrued $1 million for these dividends in other current liabilities on our condensed consolidated balance sheet as of March 31, 2015 and $2 million as of December 31, 2014.

In February 2015, the Compensation Committee approved awards with a three-year performance period beginning January 1, 2015 to December 31, 2017 for the named executives. The Compensation Committee established principal performance goals, which are (i) total shareholder return (TSR), and (ii) 2017 consolidated adjusted EBITDA margin.

The targeted number of shares of common stock that can be earned is 224,760 shares for these 2015 PSU awards. The total number of shares to be issued for these awards can range from zero to 200% of the target number of shares depending on the level of achievement of the performance goals and measures.

The expense included in the table above was calculated using a grant date common stock share price of $46.05 per share for the 2017 consolidated adjusted EBITDA margin (this is considered a performance condition) and the Monte Carlo valuation of $59.91 per share for the TSR goal (this is considered a market condition). The expense calculation is based on management’s estimate as of March 31, 2015 of the level of probable achievement of the performance goals and measures, which was determined to be at the target level, or 100% achievement (158,964 shares, net of forfeitures), for the 2017 consolidated adjusted EBITDA margin goal. The TSR portion of the plan is expensed at 100% (65,796 shares, net of forfeitures) of the grant date fair value as required by U.S. GAAP.

The following table provides details of comprehensive income (loss) for the three months ended March 31, 2015 and 2014:

(In millions)	Unrecognized Pension Items			Cumulative Translation Adjustment			Unrecognized Gains (Losses) on Derivative Instruments			Accumulated Other Comprehensive Income (Loss), Net of Taxes
Balance at December 31, 2013	$	(146.2	)	$	(134.4	)	$	3.2		$	(277.4	)
Other comprehensive income (loss) before reclassifications		(0.4	)		2.4			—			2.0
Less: amounts reclassified from accumulated other comprehensive income (loss)		2.2			—			(1.7	)		0.5
Net current period other comprehensive income (loss)		1.8			2.4			(1.7	)		2.5
Balance at March 31, 2014	$	(144.4	)	$	(132.0	)	$	1.5		$	(274.9	)

Balance at December 31, 2014	$	(236.5	)	$	(382.5	)	$	5.2		$	(613.8	)
Other comprehensive income (loss) before reclassifications		14.9			(72.8	)		4.6			(53.3	)
Less: amounts reclassified from accumulated other comprehensive income (loss)		2.4			—			(10.6	)		(8.2	)
Net current period other comprehensive income (loss)		17.3			(72.8	)		(6.0	)		(61.5	)
Balance at March 31, 2015	$	(219.2	)	$	(455.3	)	$	(0.8	)	$	(675.3	)

The following table provides detail of amounts reclassified from accumulated other comprehensive income:

	Three Months Ended
	March 31,
(In millions)	2015 (a)			2014 (a)			Location of Amount Reclassified from AOCI
Defined benefit pension plans and other post- employment benefits:
Prior service costs	$	0.2		$	0.1		(b)
Actuarial losses		(3.0	)		(2.5	)	(b)
Settlement/curtailment loss		(0.3	)		(0.5	)	(b)
Total pre-tax amount		(3.1	)		(2.9	)
Tax (expense) benefit		0.7			0.7
Net of tax		(2.4	)		(2.2	)
Net gains (losses) on cash flow hedging derivatives:
Foreign currency forward contracts		0.8			2.3		(c) Other income, net
Interest rate and currency swaps		15.1			—		(c) Interest expense
Treasury locks		0.1			0.1		(c) Interest expense
Total pre-tax amount		16.0			2.4
Tax (expense) benefit		(5.4	)		(0.7	)
Net of tax		10.6			1.7
Total reclassifications for the period	$	8.2		$	(0.5	)

The following table shows the calculation of basic and diluted net earnings per common share under the two-class method:

	Three Months Ended
	March 31,
(In millions, except per share amounts)	2015			2014⁽¹⁾
Basic Net Earnings Per Common Share:
Numerator
Net earnings available to common stockholders	$	97.2		$	70.9
Distributed and allocated undistributed net loss to non-vested restricted stockholders		(0.6	)		(0.4	)
Distributed and allocated undistributed net earnings to common Stockholders		96.6			70.5
Distributed net earnings - dividends paid to common stockholders		(27.3	)		(27.7	)
Allocation of undistributed net earnings to common Stockholders	$	69.3		$	42.8
Denominator
Weighted average number of common shares outstanding - basic		208.9			206.7
Basic net earning per common share:
Distributed net earnings to common stockholders	$	0.13		$	0.13
Allocated undistributed net earnings to common stockholders		0.33			0.21
Basic net earnings per common share:	$	0.46		$	0.34
Diluted Net Earnings Per Common Share:
Numerator
Distributed and allocated undistributed net earnings to common Stockholders	$	96.6		$	70.5
Add: Allocated undistributed net earnings to non-vested restricted Stockholders		0.5			0.3
Less: Undistributed net earnings reallocated to non-vested restricted Stockholders		(0.5	)		(0.3	)
Net earnings available to common stockholders - diluted	$	96.6		$	70.5
Denominator
Weighted average number of common shares outstanding - basic		208.9			206.7
Effect of assumed issuance of Settlement agreement shares ⁽²⁾		—			6.6
Effect of contingently issuable shares		1.2			0.6
Effect of non-vested restricted stock units		1.6			1.2
Weighted average number of common shares outstanding - diluted		211.7			215.1
Diluted net earnings per common share	$	0.46		$	0.33

As described in Note 3, “Divestiture”, on April 1, 2015, we completed the sale of our North American foam trays and absorbent pads business to NOVIPAX, a portfolio company of Atlas Holdings LLC, for gross proceeds of $82 million, subject to purchase price adjustments. The sale included our manufacturing facilities in Paxinos and Reading, PA, Indianapolis, IN, Rockingham, NC and Grenada, MS. We expect to recognize a pre-tax gain of approximately $30 million on the sale, subject to purchase price adjustments. Also, in connection with the closing, the Company and NOVIPAX entered into various other agreements, including an Intellectual Property License Agreement, Supply Agreements, a Sublease Agreement, Temporary Occupancy License Agreements and a Transition Service Agreement.

On March 16, 2015, we announced that we will realign our business in Asia, Middle East, Africa and Turkey (AMAT) in order to accelerate growth opportunities in countries across the region. We will create three clusters to be together referred to as Asia Pacific:

In addition, we will transition the Middle East, Africa and Turkey countries into our existing European regional organization, to be broadly referred to as EMEA, with more details regarding this refined structure to be provided in the near term. The new regional organization is effective starting from April 15, 2015.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information in our Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read together with our condensed consolidated financial statements and related notes set forth in Item 1 of Part I of this quarterly report on Form 10-Q, our MD&A set forth in Item 7 of Part II of our 2014 Form 10-K and our consolidated financial statements and related notes set forth in Item 8 of Part II of our 2014 Form 10-K. See Part II, Item 1A, “Risk Factors,” below and “Cautionary Notice Regarding Forward-Looking Statements,” above, and the information referenced therein, for a description of risks that we face and important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. All amounts and percentages are approximate due to rounding and all dollars are in millions, except per share amounts or where otherwise noted. When we cross-reference to a “Note,” we are referring to our “Notes to Condensed Consolidated Financial Statements,” unless the context indicates otherwise.

As a result, the Company’s new segment reporting structure consists of three reportable segments and an “Other” category and is as follows:

During the fourth quarter of 2014, we changed the method of valuing our inventories that used the last-in first-out (LIFO) method to the first-in first-out (FIFO) method, so that all of our inventories are now valued at FIFO. Certain amounts have been revised to reflect the retrospective application of this change in inventory costing method for certain U.S. inventories to the FIFO method from the LIFO method. See Note 1, “Organization and Basis of Presentation – Changes in Accounting/Retrospective Application” of the notes to condensed consolidated financial statements for further details surrounding this accounting policy change.

We are a global leader in food safety and security, facility hygiene and product protection. We serve an array of end markets including food and beverage processing, food service, retail, healthcare and industrial, and commercial and consumer applications. Our focus is on achieving quality sales growth through leveraging our geographic footprint, technological know-how and leading market positions to bring measureable, sustainable value to our customers, employees and investors. We have widely recognized and inventive brands such as Cryovac^® packaging technology, Diversey^® and TASKI^® brand cleaning and hygiene solutions and our Bubble Wrap ^® brand cushioning, Jiffy^® protective mailers, and Instapak^® foam-in-place systems.

As of December 31, 2014, we employed approximately 7,100 sales, marketing and customer service personnel throughout the world who sell and market our products to and through a large number of distributors, fabricators, converters, e-commerce and mail order fulfillment firms, and contract packaging firms as well as directly to end-users such as food processors, foodservice businesses, supermarket retailers, lodging, retail pharmaceutical companies, healthcare facilities, medical device manufacturers, and other manufacturers. We have no material long-term contracts for the distribution of our products. In 2014, no customer or affiliated group of customers accounted for 10% or more of our consolidated net sales.

Historically, net sales in our Food Care segment have tended to be slightly lower in the first quarter and slightly higher towards the end of the third quarter through the fourth quarter, due to holiday events. Net sales in our Diversey Care segment have tended to be slightly lower in the first quarter; second quarter sales represent a modest seasonal increase due to higher occupancy rates in European lodging; and the third and fourth quarters of the year are relatively the same level as the second quarter. Net sales in our Product Care segment have also tended to be slightly lower in the first quarter and higher in the mid-third quarter and through the fourth quarter due to holiday shopping season. On a consolidated basis, there is little seasonality in the business with net sales slightly lower in the first quarter and slightly higher towards the end of the third quarter through the fourth quarter. Our consolidated net earnings typically trend directionally the same as our net sales seasonality. Cash flow from operations has tended to be higher in the second half of the year, reflecting seasonality of sales and working capital changes, including the timing of certain annual incentive compensation payments.

Other factors may outweigh the effects of seasonal changes in our net earnings results including, but not limited to, changes in raw materials and other costs, foreign exchange rates, interest rates, taxes and the timing and amount of acquisition synergies and restructuring and other non-recurring charges.

Competition for most of our packaging products is based primarily on packaging performance characteristics, service and price. Since competition is also based upon innovations in packaging technology, we maintain ongoing research and development programs to enable us to maintain technological leadership. Our Food Care hygiene solutions and Diversey Care solutions businesses face a wide spectrum of competitors across each product category. Competition is both global and regional in scope and includes numerous small, local competitors with limited product portfolios and geographic reach.

Our net sales are sensitive to developments in our customers’ business or market conditions, changes in the global economy, and the effects of foreign currency translation. Our costs can vary materially due to changes in input costs, including petrochemical-related costs (primarily resin costs), which are not within our control. Consequently, our management focuses on reducing those costs that we can control and using petrochemical-based and other raw materials as efficiently as possible. We also believe that our global presence helps to insulate us from localized changes in business conditions.

We manage our businesses to generate substantial operating cash flow. We believe that our operating cash flow will permit us to continue to spend on innovative research and development and to invest in our business by means of capital expenditures for property and equipment and acquisitions. Moreover, we expect that our ability to generate substantial operating cash flow should provide us with the flexibility to repay debt and to return capital to our stockholders.

Below are the highlights of our financial performance for the three months ended March 31, 2015 and 2014:

	Three Months Ended
	March 31,						%
(In millions, except per share amounts)	2015			2014⁽¹⁾			Change
Net sales	$	1,746.4		$	1,827.7			-4.4	%
Gross profit	$	649.6		$	639.6			1.6	%
As a % of net sales		37.2	%		35.0	%
Operating profit	$	183.6		$	153.5			19.6	%
As a % of net sales		10.5	%		8.4	%
Net earnings available to common stockholders	$	97.2		$	70.9			37.1	%
Net earnings per common share – basic	$	0.46		$	0.34			35.3	%
Net earnings per common share – diluted	$	0.46		$	0.33			39.4	%
Weighted average number of common shares outstanding:
Basic		208.9			206.7
Diluted		211.7			215.1
Non-U.S. GAAP Adjusted EBITDA⁽²⁾	$	284.2		$	250.7			13.4	%
Non-U.S. GAAP Adjusted EPS	$	0.54		$	0.33			63.6	%

The following table presents a reconciliation of our U.S. GAAP EPS to non-U.S. GAAP adjusted EPS.

	Three Months Ended March 31,
	2015				2014
	Net				Net
(In millions, except per share data)	Earnings		EPS		Earnings			EPS⁽¹⁾
U.S. GAAP net earnings and EPS available to common stockholders⁽²⁾	$	97.2	$	0.46	$	70.9		$	0.33
Special items⁽³⁾		17.4		0.08		(0.4	)	$	—
Non-U.S. GAAP adjusted net earnings and EPS available to common Stockholders	$	114.6	$	0.54	$	70.5		$	0.33
Weighted average number of common shares outstanding – Diluted				211.7					215.1

For the three months ended March 31, 2015, this amount primarily includes restructuring and other associated costs related to our Fusion, EQIP and IOP programs of $19 million ($16 million, net of taxes), partially offset by a gain from the sale of our facility located in Racine, Wisconsin of approximately $3 million ($2 million, net of taxes).

For the three months ended March 31, 2014, this amount primarily includes foreign currency exchange losses related to Venezuelan subsidiaries of $15 million ($15 million, net of taxes), restructuring and other associated costs related to EQIP and IOP programs of $11 million ($8 million, net of taxes), partially offset by the gain on the Settlement agreement on February 3, 2014 of $21 million ($21 million, net of taxes). Refer to Note 17, “Commitments and Contingencies” in Part II, Item 8 of our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 for a description of the Settlement agreement (as defined therein) and related matters.

Since we are a U.S. domiciled company, we translate our foreign currency-denominated financial results into U.S. dollars. Due to the changes in the value of foreign currencies relative to the U.S. dollar, translating our financial results from foreign currencies to U.S. dollars may result in a favorable or unfavorable impact. Historically, the most significant currencies that have impacted the translation of our condensed consolidated financial results are the euro, the Australian dollar, the Brazilian real, the British pound, the Canadian dollar, the Mexican peso and the Russian ruble.

The following table presents the approximate favorable or (unfavorable) impact foreign currency translation had on some of our condensed consolidated financial results:

Net sales by geographic region for three months ended March 31, 2015 and 2014 as follows:

	March 31,						%
(In millions)	2015			2014			Change
North America	$	737.3		$	721.1			2.2	%
As a % of net sales		42.2	%		39.5	%
Europe		507.8			586.2			(13.4	)%
As a % of net sales		29.1	%		32.1	%
Latin America		177.7			187.4			(5.2	)%
As a % of net sales		10.2	%		10.3	%
AMAT⁽¹⁾		197.0			198.8			(0.9	)%
As a % of net sales		11.3	%		10.9	%
JANZ⁽²⁾		126.6			134.2			(5.7	)%
As a % of net sales		7.2	%		7.3	%
Total	$	1,746.4		$	1,827.7			(4.4	)%

By geographic region, the components of the increase in net sales for the three months ended March 31, 2015 compared to 2014 were as follows:

(In millions)	North America						Europe						Latin America						AMAT						JANZ						Total
2014 net sales	$	721.1					$	586.2					$	187.4					$	198.8					$	134.2					$	1,827.7

Volume-Units		2.4		0.3		%		2.3		0.4		%		(9.0	)	(4.8	)	%		4.9		2.5		%		5.6		4.2		%		6.2		0.3		%
Product price/mix		20.3		2.8		%		15.2		2.6		%		21.4		11.4		%		0.8		0.4		%		0.5		0.4		%		58.2		3.2		%
Total constant dollar change (Non-U.S. GAAP)		22.7		3.1		%		17.5		3.0		%		12.4		6.6		%		5.7		2.9		%		6.1		4.6		%		64.4		3.5		%
Foreign currency translation		(6.5	)	(0.9	)	%		(95.9	)	(16.4	)	%		(22.1	)	(11.8	)	%		(7.5	)	(3.8	)	%		(13.7	)	(10.2	)	%		(145.7	)	(7.9	)	%
Total		16.2		2.2		%		(78.4	)	(13.4	)	%		(9.7	)	(5.2	)	%		(1.8	)	(0.9	)	%		(7.6	)	(5.6	)	%		(81.3	)	(4.4	)	%

2015 net sales	$	737.3					$	507.8					$	177.7					$	197.0					$	126.6					$	1,746.4

As previously announced, the Company is undergoing a reorganization of its AMAT region. This reorganization involved transitioning the current AMAT region to an Asia Pacific region and moving the Middle East, Africa and Turkey countries into the Company’s existing European regional organization. This will take effect beginning in the second quarter of 2015. See Note 19, “Subsequent Events” for additional details regarding this reorganization.

	Three Months Ended
	March 31,						%
(In millions)	2015			2014			Change
Net Sales:
Food Care	$	879.8		$	904.3			(2.7	)%
As a % of Total Company net sales		50.4	%		49.5	%
Diversey Care		467.9			505.1			(7.4	)%
As a % of Total Company net sales		26.8	%		27.6	%
Product Care		377.1			393.8			(4.2	)%
As a % of Total Company net sales		21.6	%		21.5	%
Total Reportable Segments		1,724.8			1,803.2			(4.3	)%
Other		21.6			24.5			(11.8	)%
Total Company	$	1,746.4		$	1,827.7			(4.4	)%

The following tables present the components of change in net sales by our segment reporting structure for the three months ended March 31, 2015 compared with March 31, 2014. We also present the change in net sales excluding the impact of foreign currency translation, a non-U.S. GAAP measure, which we define as “constant dollar.” We believe using constant dollar measures aids in the comparability between periods as it eliminates the volatility of changes in foreign currency exchange rates.

(In millions)	Food Care						Diversey Care						Product Care						Other						Total Company
2014 Net Sales	$	904.3					$	505.1					$	393.8					$	24.5					$	1,827.7

Volume – Units		18.3		2.0		%		(0.9	)	(0.2	)	%		(9.2	)	(2.3	)	%		(2.0	)	(8.2	)	%		6.2		0.3		%
Product price/mix⁽¹⁾		34.6		3.8		%		8.5		1.7		%		13.5		3.4		%		1.6		6.6		%		58.2		3.2		%
Total constant dollar change (Non-U.S. GAAP)		52.9		5.8		%		7.6		1.5		%		4.3		1.1		%		(0.4	)	(1.6	)	%		64.4		3.5		%
Foreign currency translation		(77.4	)	(8.5	)	%		(44.8	)	(8.9	)	%		(21.0	)	(5.3	)	%		(2.5	)	(10.2	)	%		(145.7	)	(7.9	)	%
Total change (U.S. GAAP)		(24.5	)	(2.7	)	%		(37.2	)	(7.4	)	%		(16.7	)	(4.2	)	%		(2.9	)	(11.8	)	%		(81.3	)	(4.4	)	%

2015 Net Sales	$	879.8					$	467.9					$	377.1					$	21.6					$	1,746.4

The $53 million, or 6%, constant dollar increase in net sales in 2015 compared with 2014 was primarily due to:

The $8 million, or 2%, constant dollar increase in net sales in 2015 compared with 2014 was primarily due to:

The $4 million, or 1%, constant dollar increase in net sales in 2015 compared with 2014 was primarily due to:

Cost of sales for the three months ended March 31, 2015 and 2014 were as follows:

Cost of sales was impacted by favorable foreign currency translation of $89 million. On a constant dollar basis, cost of sales decreased $2 million, or less than 1%, primarily due to:

We anticipate raw material costs will continue to have a favorable impact on cost of sales in 2015 as compared with 2014; however, we also expect an unfavorable impact on net earnings related to foreign currency. Our pricing actions could be placed under negative pressure due to declines in raw material costs, and could result in a loss of sales volumes as certain customers may choose to purchase products from our competitors at lower prices.

Selling, general and administrative expenses for the three months ended March 31, 2015 and 2014 are included in the table below.

SG&A expenses were impacted by favorable foreign currency translation of $37 million. On a constant dollar basis, SG&A expenses increased $17 million, or 4%. This increase was primarily due to:

These factors were partially offset by the favorable impact of cost synergies of $9 million realized from our restructuring activities.

Amortization expense of intangible assets acquired for the three months ended March 31, 2015 and 2014 were as follows:

Amortization expense of intangibles was impacted by favorable foreign currency translation of $2 million. On a constant dollar basis, amortization expense decreased $7 million, or 22%. This decrease was primarily due to certain license agreements and software which we acquired as part of the Diversey acquisition, which were fully amortized as of September, 2014.

SARs expense includes the impact of changes in the share price of our common stock. The share price of our common stock increased approximately 7% in 2015 as compared to a decrease of approximately 3% in 2014. See Note 15, “Stockholders’ Equity,” for further details of our SARs program. As of March 31, 2015, we had approximately 500,000 SARs outstanding, all of which are now fully vested.

The Company currently estimates that it will incur aggregate costs of approximately $395 million to $405 million in connection with the implementation of this Plan, which compares to previously reported estimates of $275 million to $285 million. The increase represents our recent decision to build and own the Campus in Charlotte, North Carolina, rather than lease. The cost of the Charlotte campus is estimated to be approximately $120 million. The net cash cost of the Plan is now expected to be in the range of $330 million to $340 million. The costs associated with the Plan, the majority of which are expected to be incurred between 2015 and 2017, will primarily consist of (i) a reduction in headcount through reorganization and integration, including severance and termination benefits for employees, expected to be approximately $115 million to $120 million, and (ii) other costs associated with the Plan, primarily relating to the building costs of the Charlotte campus, rationalization, consolidation and relocation of certain portions of our global supply chain and other facilities and offices, expected to be approximately $280 million to $285 million. Included in the total cash costs, the Company anticipates approximately $175 million to $185 million of capital expenditures related to the Plan, including the building of the Charlotte campus, of which the majority is expected to be incurred between 2015 and 2016.

The Plan is currently estimated to generate annualized synergies of approximately $90 million to $100 million by the end of 2018. Additionally, the Plan is expected to generate cash and benefits of approximately $65 million from the sale of certain assets, state and local incentives in connection with the relocation of the Company’s headquarters and reductions in working capital. We achieved $1 million incremental cost synergies in the three months ended March 31, 2015. We achieved these synergies in selling, general and administrative expenses primarily in our Food Care and Diversey Care divisions.

On May 1, 2013, we commenced with our EQIP, which is an initiative to deliver meaningful cost savings and network optimization. The plan is estimated to generate annualized savings of approximately $90-$110 million by the end of 2016. We achieved $13 million incremental cost synergies in 2015 related to this program compared with 2014. We achieved these synergies in cost of sales ($6 million) and in selling, general and administrative expenses ($7 million), primarily in our Food Care and Diversey Care divisions.

In December 2011, we initiated a restructuring program associated with the integration of Diversey’s business following our acquisition of Diversey on October 3, 2011. This program is expected to be substantially completed by the end of 2015. We achieved $3 million incremental cost synergies in 2015 related to this program compared with 2014. We achieved these synergies in cost of sales ($2 million) and in selling, general and administrative expenses ($1 million), primarily in our Food Care and Diversey Care divisions.

The actual timing of future costs and cash payments related to the programs described above and our relocation activities is subject to change due to a variety of factors that may cause a portion of the costs, spending and benefits to occur later than expected. In addition, changes in foreign exchange rates may impact future costs, spending and benefits and cost synergies. See Note 9, “Restructuring and Relocation Activities,” for further discussion of the costs, cash payments and liabilities associated with these programs and relocation activities.

As of January 1, 2014, the Company changed the segment measure in which the management assesses segment performance and makes allocation decisions by segment from operating profit (a U.S. GAAP financial measure) to Adjusted EBITDA (a non-U.S. GAAP financial measure). Adjusted EBITDA is defined as Earnings before Interest Expense, Taxes, Depreciation and Amortization, adjusted to exclude the impact of special items. See “Use of Non-U.S. GAAP Information” above for a discussion of special items and further information of our use of non-U.S. GAAP measures.

We allocate and disclose depreciation and amortization expense to our segments, although property and equipment, net is not allocated to the segment assets, nor is depreciation and amortization included in the segment performance metric Adjusted EBITDA. We also allocate and disclose restructuring and other charges and impairment of goodwill and other intangible assets by segment, although it is not included in the segment performance metric Adjusted EBITDA since restructuring and other charges and impairment of goodwill and other intangible assets are categorized as special items. The accounting policies of the reportable segments and Other are the same as those applied to the condensed consolidated financial statements.

See Note 4, “Segments,” for the reconciliation of Non-U.S. GAAP Adjusted EBITDA to U.S. GAAP net earnings and other segment details.

	Three Months Ended
	March 31,
(In millions)	2015			2014⁽¹⁾
Food Care	$	190.5		$	159.0
Adjusted EBITDA Margin		21.7	%		17.6	%
Diversey Care		41.0			44.4
Adjusted EBITDA Margin		8.8	%		8.8	%
Product Care		75.6			69.1
Adjusted EBITDA Margin		20.0	%		17.5	%
Total Reportable Segments Adjusted EBITDA		307.1			272.5
Other		(22.9	)		(21.8	)
Non-U.S. GAAP Total Company Adjusted EBITDA	$	284.2		$	250.7
Adjusted EBITDA Margin		16.3	%		13.7	%

The following is a discussion of the factors that contributed to the change in Adjusted EBITDA by segment in the three months ended March 31, 2015 as compared with the prior period.

Adjusted EBITDA was impacted by unfavorable foreign currency translation of $15 million. On a constant dollar basis, Adjusted EBITDA increased $47 million, or 29%, in 2015 compared with the same period in 2014 primarily due to the impact of:

Adjusted EBITDA was impacted by unfavorable foreign currency translation of $6 million. On a constant dollar basis, Adjusted EBITDA increased $3 million, or 6%, in 2015 compared with the same period in 2014 primarily due to the impact of:

Adjusted EBITDA was impacted by unfavorable foreign currency translation of $4 million. On a constant dollar basis, Adjusted EBITDA increased $11 million, or 16%, in 2015 compared with the same period in 2014 primarily due to the impact of:

This category’s Adjusted EBITDA loss increased $1 million in 2015 as compared with 2014, primarily due to higher information systems expense in Corporate related to our ERP software implementations and upgrades.

Reconciliation of Non-U.S. GAAP Total Company Adjusted EBITDA to U.S. GAAP Net Earnings Available to Common Stockholders

The following table shows a reconciliation of Non-U.S. GAAP Total Company Adjusted EBITDA to U.S. GAAP net earnings available to common stockholders:

	Three Months Ended
	March 31,
(In millions)	2015			2014⁽¹⁾
Total Company Adjusted EBITDA	$	284.2		$	250.7
Depreciation and amortization⁽²⁾		(73.1	)		(82.8	)
Special items:
Accelerated depreciation of non-strategic assets related to restructuring programs		0.6			—
Restructuring and other charges⁽³⁾		(12.7	)		(6.1	)
Other restructuring associated costs included in cost of sales and selling general and administrative expenses		(6.4	)		(4.6	)
Relocation costs included in cost of sales and selling, general and administrative expenses		(2.6	)		—
Gain from sale of building in connection with relocation		3.5			—
SARs		(2.9	)		(0.5	)
Integration related costs		(0.7	)		(0.9	)
Foreign currency exchange net gain (losses) related to Venezuelan subsidiaries		0.8			(15.0	)
Gain from Claims Settlement in 2014 and related costs		—			21.1
Other expense, net		(0.9	)		(2.3	)
Interest expense		(58.5	)		(78.5	)
Income tax provision		34.1			10.2
Net earnings available to common stockholders	$	97.2		$	70.9

⁽³⁾Restructuring and other charges by our segment reporting structure were as follows:

The restructuring and other charges in 2015 and 2014 primarily relate to our previously announced Earnings Quality Improvement Program (EQIP). See Note 9, “Restructuring and Relocation Activities,” for further discussion.

Interest expense includes the stated interest rate on our outstanding debt, as well as the net impact of capitalized interest, the effects of interest rate swaps and the amortization of capitalized senior debt issuance costs and credit facility fees, bond discounts, and terminated treasury locks.

Interest expense for the three months ended March 31, 2015 and 2014 was as follows:

	Three Months Ended
	March 31,						2015 vs. 2015
(In millions)	2015			2014			Change
Interest expense on the amount payable for the Settlement agreement⁽¹⁾	$	—		$	4.6		$	(4.6	)
Interest expense on our various debt instruments:
12% Senior Notes due February 2014⁽²⁾		—			2.0			(2.0	)
Term Loan A due July, 2017⁽³⁾		7.2			—			7.2
Term Loan A due July 2019 (October 2016 prior to refinance)⁽³⁾		1.1			6.2			(5.1	)
Term Loan B due October 2018 ⁽³⁾		—			6.4			(6.4	)
Revolving credit facility due July 2019 (October 2016 prior to refinance)⁽³⁾		0.6			2.6			(2.0	)
8.125% Senior Notes due September 2019⁽⁴⁾		—			15.6			(15.6	)
6.50% Senior Notes due December 2020		7.0			6.6			0.4
8.375% Senior Notes due September 2021		16.0			16.0			—
4.875% Senior Notes due December 2022⁽⁴⁾		5.3			—			5.3
5.25% Senior Notes due April 2023		5.7			5.7			—
5.125% Senior Notes due December 2024⁽⁴⁾		5.6			—			5.6
6.875% Senior Notes due July 2033		7.7			7.7			—
Other interest expense		3.7			6.4			(2.7	)
Less: capitalized interest		(1.4	)		(1.3	)		(0.1	)
Total		58.5		$	78.5		$	(20.0	)

Effective January 1, 2010, Venezuela was designated a highly inflationary economy. The foreign currency exchange gains and losses we recorded in 2015 and 2014 for our Venezuelan subsidiary were the result of the significant changes in the exchange rates used to remeasure our Venezuelan subsidiary’s financial statements at the balance sheet date. We believe these gains and losses are attributable to the unstable foreign currency environment in Venezuela.

Refer to Note 17, “Commitments and Contingencies” in Part II, Item 8 of our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 for a description of the Settlement agreement (as defined therein) and related matters. In the first quarter of 2014 we recorded a gain of $21 million related to the Settlement agreement.

See Note 17, “Other Income, net,” for the components and discussion of other income, net.

Our effective income tax rate for the three months ended March 31, 2015 was 25.9%. Our effective income tax rate benefited from a favorable mix with earnings in jurisdictions with low tax rates.

Our effective income tax rate for the three months ended March 31, 2014 was 12.6%. Our effective income tax rate benefited from a favorable earnings mix with earnings in jurisdictions with low tax rates. In addition, our rate benefited from certain favorable discrete items totaling approximately $13 million, including $7 million from a favorable tax settlement and approximately $6 million from the release of reserves related to the statute of limitations and a successful judicial verdict. The favorable factors were partially offset by the $15 million foreign currency exchange losses related to Venezuelan subsidiaries with no tax benefit and the lapse of various U.S. tax provisions (the “Extenders”), including the research and development credit and certain foreign provisions.

Our effective tax rate depends on the realization of our deferred tax assets, net of our valuation allowances. We have deferred tax assets related to other accruals not yet deductible for tax purposes, foreign tax credits, U.S. and foreign net operating loss carry forwards and investment tax allowances, employee benefit items, and other items.

We are negotiating with the IRS to reach a pre-filing agreement with respect to the Grace settlement payment. The outcome of that negotiation may affect the utilization of certain tax attributes.

We have established valuation allowances to reduce our deferred tax assets to an amount that is more likely than not to be realized. Our ability to utilize our deferred tax assets depends in part upon our ability to generate future taxable income during the periods in which these temporary differences reverse or our ability to carry back any losses created by the deduction of these temporary differences. We expect to realize these assets over an extended period. If we are unable to generate sufficient future taxable income in the U.S. and certain foreign jurisdictions, or if there is a significant change in the time period within which the underlying temporary differences become taxable or deductible, we could be required to increase our valuation allowances against our deferred tax assets. Conversely, if we have sufficient future taxable income in jurisdictions where we have valuation allowances, we may be able to reverse those valuation allowances.

Our primary sources of cash are the collection of trade receivables generated from the sales of our products and services to our customers and amounts available under our existing lines of credit, including our Amended Credit Facility, and our accounts receivable securitization programs. Our primary uses of cash are payments for operating expenses, investments in working capital, capital expenditures, interest, taxes, dividends, debt obligations, restructuring expenses and other long-term liabilities. We believe that our current liquidity position and future cash flows from operations will enable us to fund our operations, including all of the items mentioned above in the next twelve months.

As of March 31, 2015, we had cash and cash equivalents of $536 million, of which approximately $355 million, or approximately 65%, was located outside of the U.S. As of March 31, 2015, there were certain foreign government regulations restricting transfers on approximately $40 million of the cash located outside of the U.S. As of March 31, 2015, our U.S. cash balances and committed liquidity facilities available to U.S. borrowers were sufficient to fund our U.S. operating requirements and capital expenditures, current debt obligations and dividends. The Company does not expect that in the near term cash located outside of the U.S. will be needed to satisfy its obligations, dividends and other demands for cash in its U.S. operations.

At March 31, 2015, we had $183 million available to us under the programs of which we had no amounts outstanding. At December 31, 2014, we had $192 million available to us under the programs of which we had $36 million outstanding at December 31, 2014. See Note 8, “Accounts Receivable Securitization Programs,” for information concerning these programs.

We have a $700 million revolving credit facility. In the first quarter of 2015, we utilized borrowings under this facility and currently have no amounts outstanding at March 31, 2015. There was $23 million outstanding under the revolving credit facility at December 31, 2014. See Note 10, “Debt and Credit Facilities,” for further details.

There was $85 million and $71 million outstanding under various lines of credit extended to our international subsidiaries at March 31, 2015 and December 31, 2014, respectively. See Note 10, “Debt and Credit Facilities,” for further details.

At March 31, 2015, we were in compliance with our financial covenants and limitations, as discussed in “Covenants” of Note 10, “Debt and Credit Facilities.”

Our cost of capital and ability to obtain external financing may be affected by our debt ratings, which the credit rating agencies review periodically. Below is a table that details our credit ratings by the various types of debt by rating agency.

These credit ratings are considered to be below investment grade. If our credit ratings are downgraded, there could be a negative impact on our ability to access capital markets and borrowing costs could increase. A credit rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time by the rating organization. Each rating should be evaluated independently of any other rating.

At March 31, 2015 and December 31, 2014, our total debt outstanding consisted of the amounts set forth in the following table.

The following table shows the changes in our consolidated cash flows in the three months ended March 31, 2015 and 2014.

Net cash provided by operating activities of $319 million in 2015 was primarily attributable to:

Net cash used in operating activities of $933 million in the first quarter of 2014was primarily attributable to:

Net cash used in investing activities in 2015 of $4 million primarily consisted of capital expenditures of $21 million related to capacity expansions to support growth in net sales and $9 million related to a business acquisition. These were partially offset by $24 million proceeds from the sale of our facility located in Racine, Wisconsin. See Note 9, “Restructuring and Relocation Activities” for further discussion on the sale of the Racine facility. Capital expenditures related to our restructuring programs were $2 million in 2015.

Net cash used in investing activities of $27 million in the first quarter of 2014 primarily consisted of capital expenditures of $28 million related to capacity expansions to support growth in net sales. Capital expenditure related to our restructuring programs was $3 million in the first quarter of 2014.

Net cash used in financing activities of $142 million in the first quarter of 2015 was primarily due to the following:

Net cash provided by financing activities of $372 million in the first quarter of 2014 was primarily due to the following:

In addition to net cash provided by operating activities, we use free cash flow as a useful measure of performance and as an indication of the strength and ability of our operations to generate cash. We define free cash flow as cash provided by operating activities less capital expenditures (which is classified as an investing activity). Free cash flow is not defined under U.S. GAAP. Therefore, it should not be considered a substitute for net income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. Free cash flow does not represent residual cash available for discretionary expenditures, including certain debt servicing requirements or non-discretionary expenditures that are not deducted from this measure. We typically generate the majority of our annual free cash flow in the second half of the year. Below are the details of free cash flow for the three months ended March 31, 2015 and 2014.

The $92 million, or 9%, increase in working capital in the three months ended March 31, 2015 was primarily due to cash flow from operations, primarily due to earnings and changes in accounts receivable, inventory and accounts payable. In addition, other current liabilities decreased by $37 million related to our 2014 profit sharing plan contribution.

The $13 million, or 1%, decrease in stockholders’ equity in 2015 compared with 2014 was primarily due to:

The Company repurchased approximately 1.4 million shares of its common stock in the three months ended March 31, 2015 for $64 million at an average price of $44.38 per share. This includes 433,181 shares purchased under an accelerated share repurchase program for $20 million at an average price of $46.17 per share. See Note 15, “Stockholders’ Equity,” for further details.

The information set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q in Note 11, “Derivatives and Hedging Activities,” under the caption “Interest Rate Swaps” is incorporated herein by reference.

The information set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q in Note 11, “Derivatives and Hedging Activities,” under the caption “Interest Rate and Currency Swaps” is incorporated herein by reference.

The information set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q in Note 11, “Derivatives and Hedging Activities,” under the caption “Net Investment Hedge” is incorporated herein by reference.

At March 31, 2015, we were party to foreign currency forward contracts, which did not have a significant impact on our liquidity.

The information set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q in Note 11, “Derivatives and Hedging Activities,” under the caption “Foreign Currency Forward Contracts” is incorporated herein by reference. For further discussion about these contracts and other financial instruments, see Part I, Item 3, “Quantitative and Qualitative Disclosures about Market Risk.”

Recently Issued Statements of Financial Accounting Standards, Accounting Guidance and Disclosure Requirements

We are subject to numerous recently issued statements of financial accounting standards, accounting guidance and disclosure requirements. Note 2, “Recently Issued Accounting Standards,” which is contained in Part I, Item 1 of this Quarterly Report on Form 10-Q, describes these new accounting standards and is incorporated herein by reference.

There have been no material changes in our critical accounting policies and estimates from those disclosed in our 2014 Annual Report on Form 10-K. For a discussion of our critical accounting policies and estimates, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in Part II, Item 7 of our 2014 Annual Report on Form 10-K, which information is incorporated herein by reference.

We are exposed to market risk from changes in the conditions in the global financial markets, interest rates, foreign currency exchange rates and commodity prices and the creditworthiness of our customers and suppliers, which may adversely affect our condensed consolidated financial condition and results of operations. We seek to minimize these risks through regular operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. We do not purchase, hold or sell derivative financial instruments for trading purposes.

From time to time, we may use interest rate swaps, collars or options to manage our exposure to fluctuations in interest rates.

The information set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q in Note 11, “Derivatives and Hedging Activities,” under the caption “Interest Rate Swaps,” is incorporated herein by reference.

See Note 12, “Fair Value Measurements and Other Financial Instruments,” for details of the methodology and inputs used to determine the fair value of our fixed rate debt. The fair value of our fixed rate debt varies with changes in interest rates. Generally, the fair value of fixed rate debt will increase as interest rates fall and decrease as interest rates rise. A hypothetical 10% increase in interest rates would result in a decrease of $112 million in the fair value of the total debt balance at March 31, 2015. These changes in the fair value of our fixed rate debt do not alter our obligations to repay the outstanding principal amount or any related interest of such debt.

As a large global organization, we face exposure to changes in foreign currency exchange rates. These exposures may change over time as business practices evolve and could materially impact our condensed consolidated financial condition and results of operations in the future. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” above for the impacts foreign currency translation had on our operations.

Economic and political events in Venezuela have exposed us to heightened levels of foreign currency exchange risk.

Effective January 1, 2010, Venezuela was designated a highly inflationary economy under U.S. GAAP, and the U.S. dollar replaced the bolivar fuerte as the functional currency for our subsidiaries in Venezuela. Accordingly, all bolivar-denominated monetary assets and liabilities were re-measured into U.S. dollars using the then current exchange rate available to us, and any changes in the exchange rate were reflected in foreign currency exchange gains and losses related to our Venezuelan subsidiaries on the condensed consolidated statements of operations.

On February 8, 2013, the Venezuelan government announced a devaluation of the bolivar exchange rate from 4.3 bolivars to the U.S. dollar to 6.3 bolivars to the U.S. dollar. We used this official exchange rate of 6.3 bolivars to the U.S. dollar to re-measure the bolivar-denominated assets and liabilities of our Venezuelan subsidiaries for U.S. GAAP financial statement presentation as of December 31, 2013. As a result of the changes in the exchange rates, we recognized a pretax loss of $13 million in 2013 due to the remeasurement of our Venezuelan subsidiaries’ financial statements and the impact due to the settlement of bolivar-denominated transactions.

On March 18, 2013, the Venezuelan government announced the creation of an alternative foreign currency mechanism called the Supplementary Foreign Currency Administration System, known as the SICAD. During December 2013, the Venezuelan government issued a new rule allowing the Central Bank to publish the average SICAD rate (previously it was prohibited by law to publish any rate different from the official exchange rate) which was 11.3 bolivars per U.S. dollar. As stated above, at December 31, 2013 we re-measured our Venezuelan subsidiaries financial statements using the official exchange rate of 6.3 bolivars to the U.S. dollar since we were not eligible to use the SICAD rate at that time.

In January 2014, the government expanded the use of SICAD and created a new agency called the National Center of Foreign Commerce or CENCOEX which replaced the Commission for the Administration of Foreign Exchange or “CADIVI.”

In February 2014, the government opened a new exchange control mechanism called SICAD 2, which would allow for more exchanges of U.S. dollars and allow more companies the ability to obtain U.S. dollars, including for dividend remittances. This market began to operate on March 24, 2014.

Therefore, there were four legal mechanisms to exchange bolivars for U.S. dollars depending on each company’s facts and circumstances:

During 2014, we evaluated which legal mechanisms were available to each Venezuelan subsidiary to access U.S. dollars and also estimated the excess cash position over the next 18 months. We concluded that as of December 31, 2014 the excess cash position for our Venezuelan subsidiaries would be re-measured at the SICAD 2 rate, which was 49.9883 at December 31, 2014, since that would be the only mechanism available to access U.S. dollars to be able to make a dividend payment. For the remaining bolivar-denominated cash balances and all other bolivar-denominated monetary assets and liabilities, we determined that since we still had access to and were receiving U.S. dollars via the CENCOEX official rate of 6.3 we continued to remeasure these items at that rate as of December 31, 2014. For any U.S. dollar denominated monetary asset or liability such amounts do not get re-measured at month-end since it is already an asset or liability denominated in U.S. dollars. However, such amounts were considered and included in the excess cash analysis and an evaluation of the applicable exchange mechanism such amounts could be obtained or settled at was considered. As a result of this evaluation, the Company reported a remeasurement loss of $20 million in 2014 of which $15 million was recorded in the first quarter of 2014.

In February 2015, the Venezuelan government announced a new foreign exchange platform called the Marginal Currency System or SIMADI. The SIMADI basically replaced the SICAD 2 rate as noted above and such rate is close to the black market rate in Venezuela. When this market opened on February 12, 2015 the rate was 170.0390 and then at March 31, 2015 it was 192.9537. The SICAD 1 and the SICAD 2 were merged into the SICAD. The opening rate was 12 for the SICAD. In addition, the CENCOEX will continue and provide preferential treatment for certain import operations such as food and medicines.

Since these changes were announced by the Venezuelan government, the new SIMADI market has had very little activity and companies have not been able to access this market to obtain U.S. dollars. In addition, the SICAD rate which is established via auctions has had no auctions held since October 2014. In addition, the specifics of which transactions are covered under this mechanism have been unclear.

Therefore, there are now 3 legal mechanisms at this time to exchange Bolívars for US dollars:

During the three months ended March 31, 2015, we evaluated which legal mechanisms were available to each Venezuelan subsidiary to access U.S. dollars and also estimated the excess cash position over the next 18 months. We concluded that as of March 31, 2015 the excess cash position for our Venezuelan subsidiaries would be re-measured at the SIMADI rate, which was 192.9537 at March 31, 2015, since the SICAD 2 rate which was 49.9883 at December 31, 2014 no longer existed at March 31, 2015. The SIMADI is expected to be the mechanism available to access US dollars to be able to make a dividend payment pending any further clarity by the government related to the SICAD. For the remaining Bolívar cash balance and all other Bolívar denominated monetary assets and liabilities, the Company determined that it would continue to re-measure these items at the CENCOEX official rate of 6.3. In 2014, the Company had access to and was receiving US dollars via the CENCOEX official rate of 6.3. However, due to the various changes in the exchange markets during the first quarter of 2015 and the lack of access and payments to Sealed Air and many companies in Venezuela, we stayed consistent with the process in December 2014 until further activity and availability in the markets becomes known. For any U.S. dollar denominated monetary asset or liability such amounts do not get re-measured at month-end since it is already an asset or liability denominated in U.S. dollars. However, such amounts were considered and included in the excess cash analysis and an evaluation of the applicable exchange mechanism such amounts could be obtained or settled at was considered. As a result of this evaluation, the Company reported a remeasurement net gain of $0.8 million as of March 31, 2015. We will continue to evaluate each reporting period the appropriate exchange rate to re-measure our financial statements based on the facts and circumstances at that time.

For the three months ended March 31, 2015, about 1% of our consolidated net sales and operating income were derived from our businesses in Venezuela. As of March 31, 2015, we had net assets of $37 million in Venezuela, which primarily consisted of cash and cash equivalents of $24 million. Also, as of March 31, 2015, our Venezuelan subsidiaries had a negative cumulative translation adjustment balance of $46 million.

The ongoing impact of the recent announcements and our ability to restore net sales and profit to levels achieved prior to the recent devaluations will be impacted by several factors. These include our ability to access the various legal mechanisms to exchange bolivars for U.S. dollars including the new SIMADI platform, any potential future devaluation of the exchange rates, any further Venezuelan government price or exchange controls, economic conditions and the availability of raw materials and utilities. In addition, depending on the future availability of U.S. dollars at the CENCOEX rate, our local U.S. dollar needs, our overall repatriation plans, including our ability to obtain government approval for the payment of dividends, which has been limited in recent years, the creditworthiness of the local depository institutions and other creditors and our ability to collect amounts due from customers and the government, including VAT receivables, we may have exposure for our local monetary assets. We continue to evaluate the impact these recent changes will have on our condensed consolidated financial statements, which could be material.

Recent economic events in Argentina, including the default on some of its international debt obligations, have exposed us to heightened levels of foreign currency exchange risks. However, as of March 31, 2015, we do not anticipate these events will have a material impact to our 2015 outlook discussed above. For the three months ended March 31, 2015, about 2% of our consolidated net sales and operating income were derived from our businesses in Argentina. As of March 31, 2015, we had net assets of $22 million (including $1 million of cash and cash equivalents) in Argentina. Also, as of March 31, 2015, our Argentina subsidiaries had a negative cumulative translation adjustment balance of $30 million.

The U.S. and the European Union (EU) have recently imposed sanctions on various sectors of the Russian economy and on transactions with certain Russian nationals and entities. Russia has also announced economic sanctions against the U.S. and other nations that include a ban on imports of certain products. These sanctions are not expected to have a material impact on our business as much of the operations in Russia support local production; however they may limit the amount of future business the Company does with customers involved in activities in Russia. As of March 31, 2015, approximately 1% of our consolidated net sales were derived from products sold into Russia.

We use foreign currency forward contracts to fix the amounts payable or receivable on some transactions denominated in foreign currencies. A hypothetical 10% adverse change in foreign exchange rates at March 31, 2015 would have caused us to pay approximately $85 million to terminate these contracts. Based on our overall foreign exchange exposure, we estimate this change would not materially affect our financial position and liquidity. The effect on our results of operations would be substantially offset by the impact of the hedged items.

Our foreign currency forward contracts are described in Note 11, “Derivatives and Hedging Activities,” contained in Part I, Item 1 of this Quarterly Report on Form 10-Q which is incorporated herein by reference.

We may use other derivative instruments from time to time, such as foreign exchange options to manage exposure to changes in foreign exchange rates and interest rate and currency swaps related to certain financing transactions. These instruments can potentially limit foreign exchange exposure and limit or adjust interest rate exposure by swapping borrowings denominated in one currency for borrowings denominated in another currency. At March 31, 2015, we had no foreign exchange options outstanding.

In connection with exercising the $100 million delayed draw under the senior secured credit facility, we entered into a series of interest rate and currency swaps. These swaps convert the U.S dollar denominated variable rate obligation under the credit facility into a fixed rate Brazilian real denominated obligation. The delayed draw and the interest rate and currency swaps are used to fund expansion and general corporate purposes of our Brazilian subsidiaries.

Our outstanding debt is generally denominated in the functional currency of the borrower. We believe that this enables us to better match operating cash flows with debt service requirements and to better match the currency of assets and liabilities. The amount of outstanding debt denominated in a functional currency other than the U.S. dollar was $489 million at March 31, 2015 and $500 million at December 31, 2014.

We are exposed to credit risk from our customers. In the normal course of business we extend credit to our customers if they satisfy pre-defined credit criteria. We maintain an allowance for doubtful accounts for estimated losses resulting from the failure of our customers to make required payments. An additional allowance may be required if the financial condition of our customers deteriorates. The allowance for doubtful accounts is maintained at a level that management assesses to be appropriate to absorb estimated losses in the accounts receivable portfolio.

Our customers may default on their obligations to us due to bankruptcy, lack of liquidity, operational failure or other reasons. Our provision for bad debt expense was $2 million for both the three months ended March 31, 2015 and 2014. The allowance for doubtful accounts was $27 million at March 31, 2015 and $29 million at December 31, 2014.

We maintain disclosure controls and procedures, as defined in Rule 13a-15 under the Securities Exchange Act of 1934, as amended, that are designed to ensure that information required to be disclosed in our reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that our employees accumulate this information and communicate it to our management, including our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), as appropriate, to allow timely decisions regarding the required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only “reasonable assurance” of achieving the desired control objectives, and management necessarily must apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As of the end of the period covered by this report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under Rule 13a-15. Our management, including our Chief Executive Officer and Chief Financial Officer, supervised and participated in this evaluation. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the “reasonable assurance” level.

There has not been any change in our internal control over financial reporting during the three months ended March 31, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

We are currently engaged in a phased implementation and upgrade of enterprise resource planning software in certain regions, which will bring all regions on to common software over the next few years. The implementation is being performed in the ordinary course of business to improve efficiency through the use of common software.

The information set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q in Note 13, “Commitments and Contingencies,” which is incorporated herein by reference. See also Part I, Item 3, “Legal Proceedings,” of our 2014 Annual Report on Form 10-K, as subsequently updated by our Quarterly Reports on Form 10-Q, as well as the information incorporated by reference in that item.

We are also involved in various other legal actions incidental to our business. We believe, after consulting with counsel, that the disposition of these other legal proceedings and matters will not have a material effect on our condensed consolidated financial condition or results of operations.

See Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2014. Except as required by the federal securities law, we undertake no obligation to update or revise any risk factor, whether as a result of new information, future events or otherwise.

(a) In March 2015, we transferred 787,463 shares of our common stock, par value $0.10 per share, to our profit sharing plan as part of our 2014 contribution to the plan. The issuance of such shares to the plan was not registered under the Securities Act of 1933, as amended, because such transaction did not involve an “offer” or “sale” of securities under Section 2(a)(3) of the Securities Act.

The table below sets forth the total number of shares of our common stock, par value $0.10 per share, that we repurchased in each month of the quarter ended March 31, 2015, the average price paid per share and the maximum number of shares that may yet be purchased under our publicly announced plans or programs.

					Total Number of		Maximum Number of
					Share Purchased as		Shares that May Yet Be
	Total Number of		Average Price		Announced Plans or		Purchased Under the
Period	Shares Purchased⁽¹⁾		Paid Per Share		Programs		Plans or Programs
	(a)		(b)		(c)
Balance as of December 31, 2014								10,118,710
January 1, 2015 through January 31, 2015		383,800	$	41.37		380,737		9,737,973
February 1, 2015 through February 28, 2015		186,710		42.33		184,210		9,553,763
March 1, 2015 through March 31, 2015		1,052,257		46.11		882,381		8,671,382
Total		1,622,767	$	44.38		1,447,328		8,671,382

	Shares withheld		Average withholding		Forfeitures under
	for tax obligations		price for shares		Omnibus Incentive
Period	and charges		in column “a”		Plan		Total
	(a)		(b)		(c)		(d)
January 1, 2015 through January 31, 2015		—	$	—		3,063		3,063
February 1, 2015 through February 28, 2015		—		—		2,500		2,500
March 1, 2015 through March 31, 2015		150,163		46.02		19,713		169,876
Total		150,163				25,276		175,439

On August 9, 2007, we announced that our Board of Directors had approved a share repurchase program authorizing us to repurchase in the aggregate up to 20 million shares of our issued and outstanding common stock (described further under the caption, “Repurchases of Capital Stock,” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II Item 7 of our Annual Report on Form 10-K). This program has no set expiration date. This program replaced our prior share repurchase program, which we terminated at that time.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Delaware		65-0654331
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)
8215 Forest Point Boulevard Charlotte, North Carolina		28273
(Address of principal executive offices)		(Zip Code)

Large accelerated filer	x	Accelerated filer	¨

Non-accelerated filer	¨ (Do not check if a smaller reporting company)	Smaller reporting company	¨

		Page

Part I. Financial Information
Condensed Consolidated Balance Sheets — March 31, 2014 and December 31, 2014		5
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2015 and 2014		6
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended March 31, 2015 and 2014		7
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2015 and 2014		8
Notes to Condensed Consolidated Financial Statements		9
Note 1 Organization and Basis of Presentation		9
Note 2 Recently Issued Accounting Standards		10
Note 3 Divestiture		11
Note 4 Segments		12
Note 5 Inventories		15
Note 6 Property Plant and Equipment, net		15
Note 7 Goodwill and Identifiable Assets		16
Note 8 Accounts Receivable Securitization Programs		17
Note 9 Restructuring and Relocation Activities		18
Note 10 Debt and Credit Facilities		20
Note 11 Derivatives and Hedging Activities		21
Note 12 Fair Value Measurements and Other Financial Instruments		23
Note 13 Income Taxes		26
Note 14 Commitments and Contingencies		26
Note 15 Stockholders’ Equity		27
Note 16 Accumulated Other Comprehensive Income (Loss)		29
Note 17 Other Income, net		30
Note 18 Net Earnings Per Common Share		31
Note 19 Subsequent Events		32
Item 2. Management’s Discussion and Analysis of Financial Condition And Results of Operation		33
Item 3. Quantitative and Qualitative Disclosures About Market Risk		51
Item 4. Controls and Procedures		54
PART II. OTHER INFORMATION
Item 1. Legal Proceedings		56
Item 1A. Risk Factors		56
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		56
Item 6. Exhibits		57
Signature		58

	March 31,		December 31,
(In millions)	2015		2014
Inventories:
Raw materials	$	104.8	$	106.3
Work in process		116.3		101.5
Finished goods		523.2		487.5
Total⁽¹⁾	$	744.3	$	695.3

	March 31,			December 31,
(In millions)	2015			2014
Land and improvements	$	98.8		$	80.9
Buildings		612.1			666.7
Machinery and equipment		2,167.0			2,238.2
Other property and equipment		123.5			140.9
Construction-in-progress		102.7			115.7
Property and equipment, gross		3,104.1			3,242.4
Accumulated depreciation and amortization		(2,190.4	)		(2,271.8	)
Property and equipment, net⁽¹⁾	$	913.7		$	970.6

	Three Month Ended
	March 31, (unaudited)
(In millions)	2015			2014
Net earnings available to common stockholders	$	97.2		$	70.9
Other comprehensive (loss) income, net of taxes:
Recognition of deferred pension items, net of taxes of $(5.2) for 2015 and $0.3 for 2014		17.3			1.8
Unrealized losses on derivative instruments, net of taxes of $5.1 for 2015 and $0.8 for 2014		(6.0	)		(1.7	)
Foreign currency translation adjustments		(72.8	)		2.4
Other comprehensive (loss) income, net of taxes		(61.5	)		2.5
Comprehensive income, net of taxes	$	35.7		$	73.4

Year	Amount (in millions)
2015	$	63.5
2016		82.7
2017		75.8
2018		63.7
Thereafter		300.7
Total	$	586.4

Fusion restructuring accrual at December 31, 2014	$	5.5
Accrual and accrual adjustments		19.9
Cash payments during 2015		(1.1	)
Effect of changes in foreign currency exchange rates		(0.4	)
Fusion restructuring accrual at March 31, 2015	$	23.9

EQIP restructuring accrual at December 31, 2014	$	41.9
Accrual and accrual adjustments		(6.9	)
Cash payments during 2015		(9.3	)
Effect of changes in foreign currency exchange rates		(2.9	)
EQIP restructuring accrual at March 31, 2015	$	22.8

IOP restructuring accrual at December 31, 2014	$	13.1
Accrual and accrual adjustments		(0.3	)
Cash payments during 2015		(3.7	)
Effect of changes in foreign currency exchange rates		(0.8	)
IOP restructuring accrual at March 31, 2015	$	8.3

	Moody’s
	Investor	Standard
	Services	& Poor’s
Corporate Rating	Ba3	BB
Senior Unsecured Rating	B1	BB
Senior Secured Credit Facility Rating	Ba1	BB+
Outlook	Stable	Stable

Exhibit Number		Description
3.1		Unofficial Composite Amended and Restated Certificate of Incorporation of the Company as currently in effect. (Exhibit 3.1 to the Company’s Registration Statement on Form S-3, Registration No. 333-108544, is incorporated herein by reference.)
3.2		Amended and Restated By-Laws of the Company as currently in effect. (Exhibit 3.1 to the Company’s Current Report on Form 8-K, Date of Report May 28, 2014, File No. 1-12139, is incorporated herein by reference.)
31.1		Certification of Jerome A. Peribere pursuant to Rule 13a-14(a), dated May 5, 2015.
31.2		Certification of Carol P. Lowe pursuant to Rule 13a-14(a), dated May 5, 2015.
32		Certification of Jerome A. Peribere and Carol P. Lowe, pursuant to 18 U.S.C. § 1350, dated May 5, 2015.
101.INS		XBRL Instance Document.
101.SCH		XBRL Taxonomy Extension Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE		XBRL Taxonomy Extension Presentation Linkbase
101.DEF		XBRL Taxonomy Extension Definition Linkbase

	Sealed Air Corporation

Date: May 5, 2015	By:	/s/ William G. Stiehl
		William G. Stiehl
		Chief Accounting Officer and Controller